Speculation Research Desk

Read this first. Speculation is not investing. The base case for most speculative positions is a large or total loss of capital. Everything on this page is educational guidance and opinion, not personalised financial advice — nothing here tells you what to buy or sell, and none of it accounts for your circumstances, tax position or risk capacity. No live prices are used; every figure and claim should be verified independently before you act on it. If you cannot afford to lose the entire amount, this page is reading material, not a shopping list.

On this page

1 · Start here
2 · Idea of the day
3 · Daily watchlist
4 · Narrative tracker
5 · Sentiment heatmap
6 · Risk tiers
7 · Scoring framework
8 · Research routine & who to follow
9 · Getting access
10 · Six-week pathway
11 · Sandbox
12 · Traps
13 · Thematic research buckets
14 · Cross-bucket risk tiering
15 · Tracking system
16 · Investor sentiment tables
17 · Jargon index
18 · Full documentation

1 · Start here — what speculation actually is

If you read one section, read this one.

Speculation is buying an asset because you expect other people's beliefs about it to change — not because you expect the asset to pay you. An investment has a claim on something: earnings, rent, a share of a productive business. You can be right about an investment even if nobody notices, because the cash eventually arrives. A speculation has no such backstop. If the crowd never arrives, you are left holding the thing.

That is a mechanical distinction, not a moral one, and it has three consequences that matter:

Time works against you. An investment compounds while you wait. A speculation burns cash, dilutes shareholders, or bleeds carry while you wait.
You cannot value your way to safety. There is no "cheap" in a pre-revenue explorer or a memecoin. Price is set entirely by narrative and flow.
Exit is part of the thesis. For an investment, "hold forever" is a valid answer. For a speculation, it is a missing plan.

The honest test. If you cannot answer "what does this pay me if the story never spreads?" with a number greater than zero, you are speculating. Say it out loud. Most bad outcomes start with someone quietly telling themselves they are investing.

	Investing	Speculation
Source of return	Cash flows the asset produces	Change in what others will pay
Main risk	You mispriced the cash flows	The story dies, or was never true
Horizon	Years to decades; time is an ally	Weeks to quarters; time is a cost
Sizing	Can be large and diversified	Must be small; assume zero
Your edge	Financial and industry analysis	Narrative timing, flow, catalyst mapping
Being early	Usually fine	Often indistinguishable from being wrong
Exit plan	Optional	Mandatory, written before entry
Correct base rate	Most positions work out	Most positions go to zero or near it

How a beginner should actually start

Fund it separately. Speculative capital is money whose complete loss changes nothing about your life. Not "would hurt but survivable" — nothing. If you can't name that number, it's zero for now.
Paper trade for one full cycle. A quarter, not a fortnight. You need to watch a narrative be born, get crowded, and die.
Set the arithmetic before the ideas. A cap on the speculative sleeve, a cap per position, a cap per theme — written down before you have an opinion about any ticker.
Make the first position boring. Its purpose is to let you observe your own behaviour, not to make money.
Journal every entry and exit. Non-negotiable. Template in plan.md §8.
Review monthly, judge the process not the P&L. A profitable position taken for a bad reason is a bad position that got lucky, and it will charge you for the lesson later.

The single most useful rule. Decide what you will do at −50% before you enter, and write it down. Not "I'd reassess" — an actual decision. People who write it down mostly follow it. People who don't, mostly freeze.

2 · Idea of the day

The single opportunity from today's scan that most rewards spending an hour on — with the full reasoning, the strongest case against it, and the specific things that would prove it wrong.

This is not a buy call, and it is deliberately not one. This section names the day's most interesting research subject and argues the case openly — but it stops short of telling you to buy, because that would be personalised financial advice and this system has no idea what your finances, timeframe or risk capacity look like. What follows is the analysis you would want before making that decision yourself. The bear case and the kill conditions below are as important as the thesis, and are placed there on purpose.

A speculative-buy upgrade with a 75% higher target turns AVITA Medical into a fresh, dated re-rating case — Bell Potter lifts AVH to $2.10 from $1.20 as reimbursement clarity and record revenue narrow the "MAC overhang" that has capped the stock for two years

EmergentTier 2

AVITA Medical (ASX: AVH / Nasdaq: RCEL), maker of the RECELL spray-on-skin burn treatment system, gained roughly 20.3% on 7 Aug after Bell Potter upgraded the stock to Speculative Buy and lifted its price target to $2.10 from $1.20, citing an improving Medicare Administrative Contractor (MAC) coverage picture, record quarterly revenue and materially lower cash burn. This is a new entrant to the watchlist, not a name this page has carried before, and the catalyst — a named analyst's dated rating and target change following a disclosed quarterly result — is exactly the kind of verifiable, attributable event this page's scoring framework rewards. · Score 66/100 · Monday 10 August 2026

Market

US/ASX dual-listed medtech — regenerative burn-care device with real, growing revenue

Hype stage

Emergent

Sentiment

Excited — a single sharp, analyst-triggered re-rating day, not yet a sustained run

Risk tier

Tier 2

Catalyst

Bell Potter upgrade and Q2 result, 7 Aug 2026 — resolved. Next scheduled result: Q3 2026, not yet dated

Score

66 / 100 (new)

Why this, and why today

AVITA's RECELL system is a real, revenue-generating product — spray-on skin cells prepared from a patient's own tissue within about 30 minutes for burn treatment — not a pre-revenue story stock. What has capped the share price for two years is a Medicare Administrative Contractor coverage dispute (the "MAC overhang") that clouded reimbursement visibility for a device whose US sales run largely through hospital and burn-centre billing. Bell Potter's note argues that overhang is "increasingly behind the business," pointing to improved reimbursement visibility, record quarterly revenue and lower cash burn as the reasons for a 75% higher price target and an explicit move to a Speculative Buy rating — Bell Potter's own label, carried through directly rather than softened. The stock responded immediately: shares closed at $1.54 on 7 Aug, up about 20.3% on the session.

What makes this the pick over a bigger, louder story elsewhere: it is the day's cleanest example of this page's own scoring logic working as designed — a dated, attributable, verifiable catalyst (a named broker's upgrade following a disclosed result) on a name with real revenue, at the Emergent stage rather than the Saturation stage several other board entries now sit at. SpaceX's Terafab story continues to develop (Intel has now been named alongside Tesla as a third Terafab partner, and SpaceX's own $60bn Cursor acquisition is reportedly set to close as early as next week — both covered in the watchlist below), but three large favourable reactions in a row on one name is a pattern this page has already flagged as saturation-adjacent twice; naming a genuinely new, smaller, better-risk-shaped entrant today is a more honest use of this section than a fourth SpaceX write-up in five runs.

The case against reading this as clean good news

A single 20% day driven by one broker's note is a thin evidentiary base. Bell Potter is one analyst voice; the upgrade has not yet been independently confirmed by a second house, and "the investment case has improved materially" is Bell Potter's own framing, not yet a consensus view.

Bell Potter's own note flags funding risk given limited liquidity — a materially higher price target and a "Speculative" label sitting side by side is the broker itself saying this remains a name that could need capital, not a name that has cleared that hurdle. A reimbursement mechanism "increasingly behind" the business is not the same as resolved; MAC coverage disputes have reopened before in this sector.

The move has already happened. A 20.3% single-day re-rating on the day the news broke means today's watchlist entry is buying after the gap, not before it — the research value from here is in whether Q3 results confirm the reimbursement and cash-burn trend Bell Potter is pricing in, not in the catalyst that has already resolved.

What would prove this wrong

A second MAC coverage dispute or reimbursement-rate reduction specific to RECELL billing codes — the exact mechanism that capped the stock previously, reopening.
No second analyst upgrade following Bell Potter's within the next reporting cycle — a lone broker call that isn't corroborated is weaker evidence than a cluster of independent ones.
A capital raise or equity issuance that confirms the "funding risk given limited liquidity" Bell Potter itself flagged, diluting the re-rating thesis before it plays out.
Q3 2026 revenue growth decelerating from the "record quarterly revenue" pace cited as the basis for the upgrade.

Risk-tier reality check

Tier 2 — listed, liquid (dual-listed ASX and Nasdaq) and with real, disclosed, growing revenue, which is more structure than a pure story stock, but the broker's own flag of funding risk given limited liquidity and the history of a reimbursement dispute capping the stock for two years keep this out of Tier 1. Not Tier 3: disclosure is adequate and the product has demonstrated commercial revenue, not just a pipeline.

How you'd actually research this yourself

Read Bell Potter's note in full (via a broker platform or the company's own investor relations page) rather than relying on the headline target change — the reasoning matters more than the number.
Check AVITA's most recent 10-Q and MAC correspondence for the specific billing codes and coverage determination language, the same way this page tracks Orthofix's HCPCS code exposure elsewhere on the watchlist.
Watch for a second analyst house publishing on the name before treating Bell Potter's view as anything more than one informed opinion.

What did not get picked today, and why

SpaceX listed-float mechanics (91, up 2) — Intel has now been named as a third Terafab partner alongside Tesla, SpaceX confirmed it will build natural gas power plants to supply the Texas facility, and SpaceX's reported $60bn acquisition of AI-coding startup Cursor is said to be closing as early as next week. Genuine, material, dated-adjacent developments, but this is the third consecutive run in which SpaceX news has been the loudest thing on the board, and naming it a fourth time risks exactly the "everybody looked at one name" failure this page has flagged in its own reimbursement-cell commentary. Fully covered in the watchlist below instead.

Medicare reimbursement calendar (76, down 1) — Stifel trimmed its Orthofix price target to $13 from $15 while keeping a Buy rating, describing Q2 as "relatively mixed" despite the raised guidance already logged yesterday. A genuine, dated, mildly negative analyst data point, but one that nuances an already-argued thesis rather than opening a new one — and the same reimbursement-clarity mechanism it tracks is exactly what AVITA's pick today expresses in a second, unrelated name.

ASX lithium recovery trade (49, down 1) — Elevra Lithium traded down a further 4.83% on 3 Aug, continuing the bearish turn logged yesterday against the three-way supply-restart news. Not picked because it is a continuation of an already-argued negative data point rather than a new development.

Quantum computing pure-plays (62, held) — Rigetti's up-to-$100m potential CHIPS Act funding and a Wedbush note flagging renewed ahead-of-earnings optimism carry forward as colour on an already fully-resolved earnings cluster, not new evidence of the discrimination-versus-basket question this entry has tracked for several runs.

How this pick is made. SpaceX again holds the highest score on the board (91, up from 89), but this is the third consecutive run in which its own escalating news cycle has been the obvious pick, and repeatedly naming the loudest name is a bias this page's own framework exists to catch — see the reimbursement cell's long-standing warning about mistaking "everybody looked at one name" for "the pattern." AVITA Medical is today's better test of the system: a smaller, genuinely new, dated and attributable catalyst on a real-revenue name at an earlier hype stage, which is closer to what this page's scoring dimensions are actually designed to reward than a fourth write-up of an already-euphoric mega-cap. Every previous pick and how it has aged is logged permanently in history.md.

3 · Daily watchlist

Opportunities and themes flagged by the daily scan, sorted by research score. These are research subjects, not recommendations. A high score means "worth understanding," never "worth buying." No prices or market caps are shown — this system does not use live market data, and every name below must be independently verified. Named companies are examples of where a narrative is being expressed, not endorsements. Ticker chips link to filings, not to a broker — ASX:XXX goes to the company's ASX announcements page and XXX to its SEC EDGAR filings, because that's where a capital raise or a drill result actually surfaces first. On why there are no buy links, see §9.

Tier 1 High risk, grounded narrative

Tier 2 Very high risk, hype-driven

Tier 3 Extreme risk, low liquidity

Tier 4 Meme-level — assume zero

Opportunity / theme	Market	Narrative	Catalyst	Hype stage	Sentiment	Tier	Score	Source
SpaceX listed-float mechanics Supersedes the generic space-speculation entry SPCX RKLB ASTS	US	New this run: Intel has been named alongside Tesla as a third partner in Terafab, the Texas chip megaproject, with commentary describing the $16.8bn figure as only the first phase and a full buildout potentially reaching $119bn. SpaceX also confirmed it will build its own natural gas power plants to supply Terafab, and its reported $60bn acquisition of AI-coding startup Cursor is said to be closing as early as next week — a second, unrelated large capital commitment inside the same fortnight. The stock continued higher, trading up around 16.7% on 9 Aug at $133.11. The 7 Aug Terafab announcement and 23% two-day rally, the 6 Aug unlock (~911.5m shares, ~$100bn, absorbed without a selloff) and the 4 Aug Q2 beat ($7.81bn revenue, +92% YoY) all carry forward. Further ~7% tranches ~21 Aug and ~10 Sep; a ~28% release triggered by the Q3 report; the remainder 8 Dec 2026. Musk's ~6.4bn shares stay locked to 12 Jun 2027.	Terafab groundbreaking and hiring, undated beyond the announcement. Cursor acquisition reportedly closing "as early as next week" — undated precisely. Q2 results 4 Aug 2026 — resolved. Unlock 6 Aug 2026 — resolved. Next scheduled float events: further ~7% tranches ~21 Aug and ~10 Sep 2026.	Acceleration	Euphoric — a third large favourable catalyst inside two weeks	Tier 1	91	Timothy Sykes — SPCX jumps as Terafab megaproject unveiled, Simply Wall St — Terafab and new mobile network, Foreign Policy Journal — SPCX rockets on Q2, Terafab, lockup relief, TechCrunch — Tesla & SpaceX $16.8bn Terafab, Bloomberg — $327bn two-day rally
AVITA Medical — reimbursement-driven re-rating New today RECELL spray-on-skin burn treatment, dual-listed ASX/Nasdaq ASX:AVH RCEL	ASX/US	New entrant: Bell Potter upgraded AVITA Medical to Speculative Buy and lifted its price target to $2.10 from $1.20, arguing the Medicare Administrative Contractor ("MAC") reimbursement overhang that has capped the stock for two years is "increasingly behind the business," pointing to record quarterly revenue, improved reimbursement visibility and materially lower cash burn. Shares closed at $1.54 on 7 Aug, up roughly 20.3% on the session. Bell Potter's own note flags funding risk given limited liquidity alongside the upgrade. RECELL is a real, revenue-generating regenerative-medicine burn treatment, not a pre-revenue story.	Bell Potter upgrade and Q2 result 7 Aug 2026 — resolved. Next scheduled result: Q3 2026, not yet dated. Whether a second analyst house corroborates the reimbursement-clarity read is the next real test.	Emergent	Excited	Tier 2	66	Kalkine — AVITA Medical share price update, Bell Potter — AVITA Medical coverage, Motley Fool AU — 5 things to watch, 10 Aug
Medicare reimbursement calendar US small-cap medtech & diagnostics with concentrated billing-code exposure OFIX	US	For a class of US small-cap device and diagnostics companies, revenue runs through one or two Medicare billing codes, so a regulator's published rate table is closer to the fundamentals than the investor deck. Orthofix Medical (Nasdaq: OFIX), whose core revenue bills through HCPCS codes E0747, E0748 and E0760, remains the reference case after the 1 Jul CMS reversal restoring prior reimbursement for non-invasive bone growth stimulators. Code concentration is verifiable from primary filings; the mechanism is proven material. New this run: Orthofix raised its full-year 2026 guidance to $845m–$855m in net sales, explicitly attributing the increase to the restored bone-growth-stimulator reimbursement — a specific, dated confirmation that a regulator's rate table moved this company's numbers, not just its share price. New this run, and mildly negative: Stifel analyst Thomas Stephan trimmed his price target on Orthofix to $13 from $15 while keeping a Buy rating, describing the Q2 result as "relatively mixed" despite the raised guidance — a genuine, dated, named-analyst nuance rather than a reversal. The still-open question is whether the CY2027 rulemaking calendar produces a comparable move or whether the pattern only fires through undated mid-cycle changes; the proposed conversion-factor figures ($33.17 qualifying APM, a 1.19% fall; $32.84 non-APM, a 1.68% fall) remain unchanged in substance against the CY2027 proposed rule.	CMS-1848-P issued 14 Jul 2026; 60-day comment period closes 14 Sep 2026; final rule in the autumn; rates effective 1 Jan 2027. Conversion factor proposed to fall from $33.5675 to $33.1693 (APM) and $33.4009 to $32.8409 (non-APM). Statutory and dated — but the most material moves so far have come from undated mid-cycle changes.	Latent → Emergent	Neutral, mixed analyst read	Tier 2	76	CMS, StockTitan — Orthofix Q2 2026 results, raised guidance, Seeking Alpha — Q2 2026 earnings call transcript, Stifel target cut, Holland & Knight, Orthofix 8-K via StockTitan
Rare earths and the 10 November cliff ASX explorers & developers ASX:LYC ASX:ILU ASX:ARU ASX:BRE ASX:LIN	ASX	China suspended its October 2025 export controls until 10 Nov 2026 as part of the trade truce; the April 2025 licensing regime was never suspended. New this run, confirming rather than new: the second wave of controls — covering five rare earth elements (holmium, erbium, thulium, europium and ytterbium) plus related products, equipment and technologies — is confirmed rescheduled to the same 10 Nov 2026 date this entry already tracks, having originally been set for 7 Nov 2025. This sharpens what actually resumes on the cliff date rather than changing it. The NdPr alloy benchmark and China's Rare Earth Price Index (267.0) carry forward unrefreshed. Enforcement-escalation detail (14 EU entities added 24 Jul, 10 US firms in June, MOFCOM Announcement No. 26, two Japanese nationals detained in Dalian in May over an alleged rare-earth smuggling case) stands, with the Dalian detentions logged as a new, if lower-weight, enforcement data point. The IEA's estimate that full enforcement could put roughly $6.5 trillion of downstream global production at risk is unchanged.	10 Nov 2026 — the suspension expires, now specifically confirmed to include the five-element second wave (Ho, Er, Tm, Eu, Yb). Unless Beijing extends or replaces it, a broad licensing regime with a presumption against approval returns. Hard-dated; outcome is a sovereign decision.	Acceleration	Excited	Tier 2	77	China Briefing, Rare Earth Exchanges — index eases to 267.0, MacroMicro — Nd/Pr metal prices, 3 Aug, Crux Investor — NdPr surge (carried forward), CSIS
Australian sovereign defence capability Counter-drone and sovereign manufacture ASX:DRO ASX:EOS ASX:ASB ASX:BIS ASX:CDA	ASX	Sovereign counter-drone procurement (Mission Syracuse, $37.4m committed to date) and the listed pure-play's HY26 trading update remain the core of this entry. Confirming detail this run: secondary coverage re-cited the guided $250m–$270m FY26 revenue range (15–25% growth) and the roughly 60% H1 gross margin, and a previously-logged $23.2m European reseller order package was reconfirmed as already folded into the $206m committed-revenue figure — not a fresh addition. The audited first-half FY26 results and investor call remain scheduled for 26 August 2026; the company's own explanation for the gross-margin drop to 60% from 65% (hardware pass-through, currency, writedowns) stands untested until that date. Thirteenth consecutive run without a fresh development specific to this entry.	The audited HY26 result on 26 August 2026 — a fixed date, now sixteen days away — containing the segment and channel detail the trading update omitted. Further Mission Syracuse tranches behind it.	Acceleration	Excited, turning	Tier 2	71	Defence Ministers, ASCA, Kalkine — RfAI-3 & committed revenue, Stocks Down Under, Capital.com
Prediction markets as an asset class Kalshi, Polymarket and CFTC-regulated venues	Alt	Growth and integrity/legal risk continue to accelerate on the same platforms simultaneously. New this run: Google's Chrome Web Store updated its policy to prohibit extensions facilitating real-money prediction-market trading, enforced from 1 Aug 2026, putting more than 50 Kalshi- and Polymarket-linked browser tools at risk of discontinuation — a distribution-layer risk distinct from the state-court fights this entry has tracked to date. On the other side of the ledger, Polymarket filed suit against New Mexico's Attorney General, arguing the state's refusal to delay enforcement created an immediate threat to the platform — the first instance logged here of a platform going on the offensive rather than defending a state action, a genuinely new tactical development. Michigan's injunction (the third state, after Nevada and Massachusetts) carries forward from yesterday. Kalshi's May monthly volume record ($17.91bn) and Polymarket's regulated US path via its QCEX acquisition remain the most recent confirmed growth data points; combined monthly global volume was reported around $24bn in April 2026.	Whether the Chrome Web Store policy meaningfully cuts retail trading access; the outcome of Polymarket's New Mexico suit; the Michigan injunction being appealed or narrowed; the nine-state federal-preemption fight continuing on the merits; any firming of Kalshi's IPO timeline. A cluster of near-term tests, not one clean date.	Acceleration	Cautious, but now pushing back rather than only absorbing losses	Tier 2	73	RotoWire — prediction markets legal timeline, Michigan injunction, Yahoo Finance — Kalshi, Polymarket expand as surveillance tightens, CFTC — Enforcement Division prediction-markets advisory, CoinSpectator — Minnesota loses first round, CBS News — states and prediction-market regulation
Critical-minerals capital discrimination Funded developers vs unfunded explorers ASX:BGD	ASX	A widening gap between explorers who can show funding, technical progress and a path to cash flow, and those who cannot. Checked, not material: Barton Gold's shares stopped OTCQB quotation in the US on 31 Jul, moving to unsponsored OTC Pink quotation with its US branch register set to close around 1 Dec 2026 — a US-listing mechanics change affecting a small US-held share count (~0.2% of shares outstanding), unrelated to the funded/unfunded divergence thesis this entry actually tracks and not treated as evidence either way. The Barton Gold placement clarification from three runs ago (two genuine, separate raises: $15m Franklin Templeton-led in October 2025, $25.9m oversubscribed in June 2026) carries forward unrefreshed. No new information specific to this entry's named set this run — a twelfth consecutive run without a fresh, dated test result for the companies this entry actually tracks.	Capital raisings through Aug–Sep as the real test of whether disclosed Appendix 5B runway predicts who raises. The lodgement deadline itself has passed; what's left is a lagging, undated confirmation window.	Emergent	Cautious	Tier 2	69	ASX Appendix 5B, Kalkine — Barton Gold $25.5–25.9m placement, Small Caps — $15m Franklin Templeton raise, GlobeNewswire — Predictive Discovery quarterly report
ASX copper discovery cycle Solstice Minerals — Nanadie Well, WA ASX:SLS	ASX	A discovery-drought narrative breaking, carried forward from yesterday's fresh evidence. Solstice's original diamond hole returned a combined 629.1m at 0.50% Cu and 0.17g/t Au from surface, including 30.7m at 1.41% Cu from 461.5m. The first RC assays, dated 3 Aug 2026 — 51m at 1.03% Cu and 0.29g/t Au from 194m (NANRC041), 97m at 0.57% Cu from 173m (NANRC038), and 30m at 1.15% Cu from 240m (NANRC035) — confirmed the mineralised system extends across roughly 1.2km of strike, with an emerging higher-grade corridor along the eastern 100m of the host gabbro body. New this run, a funding-risk data point rather than a fresh assay: secondary coverage confirms cash reserves above $45m, addressing the standard exploration-funding-risk question for this entry independent of the still-pending assay flow. The same 3 Aug assay set otherwise carries forward unrefreshed for a seventh day; assays from more than 40 further holes remain pending through H2 2026.	Further assays from the more than 40 remaining holes, reporting progressively through H2 2026, then a resource update. Sequenced and material, but individual results are undated — the standard weakness of exploration catalysts.	Emergent	Excited	Tier 3	57	Kalkine — exceptional high-grade RC results, Motley Fool AU — system grows, Small Caps — cash reserves above $45m, Australian Mining — higher-grade corridor, Stocks Down Under (carried forward)
Uranium & nuclear fuel cycle ASX uranium developers ASX:BOE ASX:DYL ASX:BMN ASX:PDN ASX:AGE	ASX	Australia and India finalised the administrative arrangements enabling uranium exports on 9 Jul 2026 during Modi's Melbourne visit, ending a decade-long stalemate under the 2026 Australia-India Nuclear Cooperation framework. Exports remain restricted to civilian use under IAEA safeguards and commercial offtakes are still to be negotiated within a stated 12–18 month window of the framework signing. Mixed signal this run, no change specific to this entry's named tickers' India exposure: Paladin Energy's Langer Heinrich ramp-up is confirmed producing (1.29m lb U3O8 in the quarter at ~US$68.30/lb average sales price) with the stock back around A$13, while separate coverage headlines BOE and PDN as "struggling" even as the physical U3O8 spot price ended July at US$86.50/lb, up US$1.25/lb from June. The two reads roughly offset — an eleventh consecutive run with no named producers, volumes or commercial offtakes specific to the India export thesis.	Commercial offtake contracts between Australian miners and Indian utilities — the next real catalyst, and currently undated. Datacentre power deals and utility contracting cycles behind it.	Acceleration	Excited, mixed	Tier 2	54	Al Jazeera, Proactive, Market Index — BOE, PDN struggling despite tailwinds, FNArena — Uranium Week, spot price, India News Network
ASX antimony & critical-mineral explorers Krakatoa (Zopkhito, Georgia) and peers ASX:KTA ASX:NPM ASX:AKN ASX:AT4 ASX:CHW	ASX	Antimony's strategic-mineral status plus Chinese export controls continues to pull tiny explorers into a large theme. New this run: the 2026 Zopkhito field season is now confirmed running roughly two months ahead of last year's equivalent program, with four surface diamond holes and 13 underground holes completed and the first drill core logged, sampled and now in transit to a laboratory in Türkiye for analysis. No new information this run — the accelerated-timeline update carries forward unrefreshed; the same June-quarter visual-stibnite intervals (2.86m including a 60cm zone at roughly 50% visual stibnite; a separate 44cm interval at around 25%) remain the most recent public grade indication, alongside a re-cited foreign resource estimate of 225,000t at 11.6% Sb for 26,000t contained antimony. Thirteenth consecutive run with visual estimates only. This entry remains the clearest candidate on the board for a future staleness-based retirement if assays do not follow, though it is still well short of the 45-day no-information threshold.	Assay results from the Zopkhito campaign, now in transit to a Turkish laboratory, and a maiden JORC-compliant resource estimate. Dated, binary and material, with a brutal outcome distribution. Visual estimates are not assays.	Emergent	Cautious	Tier 3	52	Mining.com.au — 2026 field season accelerated, Proactive — June-quarter update, Proactive — visual antimony confirmed
Quantum computing pure-plays Changed +1 The pure-play complex — all three names now resolved IONQ RGTI QBTS QUBT	US	The three-name cluster reported in full two runs ago; today's update is the follow-up test this page named as the next honest check. New this run: sell-side price targets moved in the same direction as Friday's share reactions — Mizuho cut its Rigetti target from $33 to $27 while keeping an Outperform rating, and Canaccord's Kingsley Crane cut D-Wave's target from $41 to $35 while keeping a Buy rating. Neither is a full reversal of view (both analysts kept constructive ratings), but both moved down in step with the muted-to-negative share reactions rather than staying flat despite them, which is what would be expected if the divergence read two runs ago reflected genuine fundamental discrimination rather than short-dated positioning. New this run, colour rather than a fresh test: secondary coverage specifies Rigetti's CHIPS-Act figure as up to $100m in potential funding against $569m cash and zero debt, and a Wedbush note ahead of the reporting cluster is cited as the source of some of the pre-earnings optimism already logged. IonQ's record Q2 revenue, guidance raise and near-zero after-hours reaction (5 Aug) and Rigetti's/D-Wave's full results (6 Aug) all carry forward unrefreshed. All three names remain down roughly 30% over the trailing month even after the week's ~20%+ snapback — the wider frame this entry's Saturation tag reflects.	All three names' Q3 2026 results, not yet scheduled. Rigetti's CHIPS-Act LOI (up to $100m) progressing to a signed award; further error-correction milestones remain undated.	Saturation	Discriminating by fundamentals — analyst targets now confirming the share-price divergence	Tier 2	62	StockTitan — Rigetti Q2 results, $5.1m revenue, Seeking Alpha — Rigetti dips on mixed Q2, Benzinga — D-Wave drops after earnings miss, LevelFields — D-Wave Q2 revenue miss detail, Benzinga — IonQ Q2 double beat (carried forward)
ASX lithium recovery trade Elevra Lithium (ex-Sayona) and peers ASX:ELV ASX:LTR ASX:PLS	ASX	An ongoing debate about the shape and timing of lithium price recovery. New this run, and continuing the bearish turn: Elevra Lithium traded down a further 4.83% on 3 Aug, extending yesterday's supply-restart-driven weakness (Mineral Resources' Bald Hill restart, Core Lithium's Finniss restart, CATL's Jianxiawo permit clearance) against reports of Chinese battery-grade carbonate below CNY 145,000/t, a five-month low. This has not yet been reconciled against this entry's own CNY 140,000/t battery-grade print, itself still not reconciled against the ¥146,000/t figure flagged in prior runs. The CME's new lithium carbonate options contract still launches 17 Aug 2026.	Spodumene spot pricing through Q3; further quarterly production reports; whether the Bald Hill, Finniss and Jianxiawo restarts actually add meaningful volume; CME lithium carbonate options launch 17 Aug 2026. Recurring, weakly dated.	Emergent	Cautious, bearish turn continuing	Tier 2	49	Investing News Network — lithium price moves, supply restarts, Kalkine — Elevra Lithium, sharp drop, Elevra Lithium Quarterly Activities Report, Fastmarkets — lithium carbonate CME contract
Nasdaq minimum-bid delisting mechanics ENvue Medical — reverse split ahead of a compliance deadline FEED	US	A recurring, structural pattern rather than a story specific to one company: a distressed microcap facing Nasdaq's $1.00 minimum-bid-price rule proposes a reverse stock split to stay listed, and WSB attention spikes around the vote. No new information this run — ENvue Medical (maker of UroShield, PainShield and WoundShield — real products with signed hospital contracts, $2.55m 2025 revenue against a $16.78m loss) remains this page's example, with the 14 Aug shareholder vote on a reverse split of between 1-for-2 and 1-for-50 unchanged, following two prior reverse splits in 2025 that exhausted the standard Nasdaq compliance grace period. No new information this run — the 14 Aug special meeting is unchanged, now four days away, called after Nasdaq's 10 Jul notice that the stock traded below $1.00 for 30 consecutive business days.	Special shareholder meeting 14 Aug 2026 — the reverse-split vote itself, dated and binding. Next earnings report 18 Aug 2026. Both fixed, both near-term, both mechanical rather than speculative about outcome.	Emergent	Excited, thin	Tier 3	43	StockTitan — DEF 14A proxy, AltIndex — WSB mention tracker, Simply Wall St — company overview

Retired from the watchlist today

No retirements today. The semiconductor & AI-infrastructure complex retirement (ASML/MU, score-fall rule, 8 Aug) stands; full reasoning remains in history.md's Run #12 entry. One new opportunity met the bar today: AVITA Medical, a genuinely new, dated, attributable catalyst (Bell Potter's Speculative Buy upgrade) on a real-revenue medtech name, discussed in full as today's Idea of the Day. Every other change today is an update to an existing entry. Antimony (52, thirteenth run of visual estimates only) remains the clearest staleness-based candidate still on the board. Active count rises to 13.

Previously retired: Semiconductor & AI-infrastructure complex (ASML, MU — score fell more than 20 points from its Run #1 entry score with no fresh catalyst to arrest the slide, 8 Aug), ASX IPO-flip trade (FDC Consolidated Holdings, primary-source finding invalidated the catalyst, 31 Jul), BrainChip / neuromorphic commercialisation (narrative in Decay, 31 Jul), ASX gold-developer consolidation (catalyst passed, 29 Jul), graded collectibles & Pokémon (narrative reached Decay, 29 Jul), generic space & satellite speculation (superseded by the SPCX float-mechanics entry, 29 Jul). Full reasoning and sources for each are permanently recorded in history.md.

How to read the scores. The score ranks research interest, not expected return — see §7. Ten longitudinal patterns are now visible, the newest of which is a retirement. First, a stale score can eventually cross a mechanical rule even without fresh bad news: semiconductors went 58 → 48 → 47 → 45 → 46 → 44 → 42 → 40 → 40 → 39 → 38 → 37 across twelve runs, and the final point crossed the "more than 20 points" score-fall retirement trigger this page had flagged as approaching for three consecutive runs — retired today, discussed in full as today's Idea of the Day. Second, a score can rise while the reason for it weakens — the reimbursement entry went 83 → 85 → 84 → 83 → 82 → 81 → 80 → 79 → 78 → 77 → 76 across eleven runs while its dated-catalyst premise kept getting undercut by undated events proving the mechanism instead. Third, a narrative's score can move on the resolution of its underlying catalyst rather than on sentiment: the SpaceX entry fell 88 → 83 on its earnings verdict, rose 83 → 84 on a partial pre-unlock recovery, then rose again 84 → 86 once the unlock itself resolved positively, and has now held flat at 86 for a run with nothing new to grade. Fourth, dormant entries can move sharply the moment real evidence arrives, then go quiet just as fast: Solstice's copper entry jumped 52 → 57 on its first fresh assays in six runs, then held flat at 56 for three runs since. Fifth, a genuine sourcing ambiguity can resolve without a dramatic reversal: lithium's three-way benchmark discrepancy (140,000/t, 146,000/t, 72,000/t) turned out to be two different products — 99.5% battery grade and 99% industrial grade — being quoted side by side, not three conflicting prices for one thing; the entry moved 51 → 52 on that clarification. Sixth, a Saturation-stage narrative meeting good news and not moving on it can turn out to be one data point in a larger, more differentiated pattern rather than a settled rule, and that read can then be confirmed by a second, independent signal: IonQ's near-zero reaction lifted the quantum entry 51 → 59; the completed three-name cluster's divergent reactions moved it 59 → 61; and today, sell-side analysts cutting price targets on Rigetti and D-Wave in the same direction as the share moves lifted it a further point, 61 → 62 — three separate pieces of evidence pointing the same way rather than one loud data point. Seventh, a primary-source check can neutralise a data point rather than resolve it: the neodymium/praseodymium ~$245/kg conflict flagged several runs ago was checked repeatedly, was not reproduced, and remains set aside as a likely sourcing error. Eighth, the highest raw score on the board and the Idea of the Day pick regularly diverge on purpose: SpaceX holds the highest score again today (86, unchanged) but was not picked, because a mechanical retirement rule quietly crossing its own threshold was judged the more consequential test of this page's own discipline. Ninth, operational progress without a dated result still moves a score, but by less than a dated result would: Krakatoa's confirmed accelerated drilling timeline lifted its score by a single point three runs ago and has now sat flat for two runs since, pending assays. Tenth, a retirement under the score-fall rule is not necessarily a verdict that the underlying narrative was wrong — semiconductors retired on accumulated absence of fresh validation for a Decay-stage theme, not on a structural deterioration, and the wider AI infrastructure theme it sat inside remains tracked in §13 with a dated catalyst window opening 15 Aug 2026. Eleventh: a single entry can migrate between this page's own tracked themes in real time — SpaceX's $16.8bn Terafab commitment pulls a float-mechanics entry directly into the AI-infrastructure narrative one day after that narrative's own dedicated watchlist entry retired, a reminder that theme boundaries on this page are analytical conveniences, not the market's. Twelfth, and new today: the highest-scoring entry on the board and the day's pick can diverge on purpose for a different reason than before — not a retirement crossing its own threshold, but a deliberate choice to name a smaller, newer, better-risk-shaped catalyst (AVITA Medical, 66) over a third consecutive write-up of an already-euphoric mega-cap (SpaceX, 91) — the same discipline the reimbursement cell's own commentary has warned about applies to this page's own Idea of the Day selection, not just to community sentiment. If a future run ever produces the highest scores on the most-discussed names for the wrong reasons, the scoring has drifted. A high score on a Tier 3 asset still means assume total loss.

4 · Narrative tracker

A narrative is a compressed story that lets people buy without doing work. Your job is to identify it early, judge its runway, and know when it has become consensus.

Stage 1

Latent

A real change occurs — policy, technology, supply shock. Almost nobody connects it to tickers. Best risk/reward, hardest to distinguish from noise.

Stage 2

Emergent

Specialist forums and a few analysts name the theme. Ticker lists circulate. Research effort pays most here.

Stage 3

Acceleration

Mainstream media picks it up. New listings, raisings and name-changes appear to serve demand. Prices go vertical.

Stage 4

Saturation

General news coverage, an ETF launches, the marginal buyer knows nothing. Good news stops moving prices — the key tell.

Stage 5

Decay

The story isn't disproven, it gets boring. Volume falls first, price follows.

Narrative	Stage	Direction	First logged	What advances it	What kills it
Non-China critical minerals	Acceleration	→ Holding — index and alloy price unchanged; a separate oxide series checked but not reconciled	28 Jul 2026	The 10 Nov 2026 expiry of China's control suspension; NdPr alloy at ~$133.67/kg (+0.49% from 1 Jul); MOFCOM Announcement No. 26 enforcement machinery; 14 EU entities added 24 Jul on top of 10 US firms in June; IEA warning of $6.5tn at risk	Beijing extending the suspension; Chinese supply normalising further; a funded competitor commissioning early
AI infrastructure buildout	Saturation → Decay	↓ Its clearest watchlist expression (semiconductors) retired today on accumulated score decay	28 Jul 2026	Capex guidance upgrades; power and cooling constraints; the 15 Aug 2026 Q3 earnings/capex window tracked in §13	Partly firing, with pushback. Chinese immersion DUV tools entering production, but JPMorgan notes a handful of tools is not high-volume manufacturing; AI-debt concerns continue; the watchlist entry retired on stale score today without new evidence either way
Quantum as "the next AI"	Saturation	↕ Analyst re-ratings now confirming the completed cluster's divergent reactions	28 Jul 2026	IonQ's $1.8bn SkyWater acquisition closed 31 Jul; record Q2 revenue ($80.05m, +287% YoY) and a raised FY guide (5 Aug); Rigetti's roughly in-line Q2 and CHIPS-Act LOI; further error-correction milestones	Confirmed by a second signal. Reaction size tracked surprise size across all three names two runs ago; today, Mizuho cutting its Rigetti target ($33→$27) and Canaccord cutting its D-Wave target ($41→$35) — both in the same direction as the share reactions — is independent evidence for genuine fundamental discrimination rather than short-dated positioning
Nuclear / uranium revival	Acceleration	→ Flat, seventh run (next catalyst still undated)	28 Jul 2026	The Australia–India administrative arrangements finalised 9 Jul, with offtakes stated to follow within 12–18 months; datacentre power deals; utility contracting	Offtake negotiations stalling; project delays; an incident anywhere in the world
Prediction markets go mainstream	Acceleration	↕ A new distribution-layer risk (Google's Chrome extension ban) lands against a new offensive legal move (Polymarket suing New Mexico's AG) — losses and pushback in the same run	28 Jul 2026	Volume growth continuing (Kalshi's ninth consecutive monthly record, $17.91bn in May; ~$24bn combined global monthly volume in April); Kalshi CEO confirming early IPO talks (up to $40bn valuation); ICE's $2bn stake in Polymarket; Polymarket's Yankees Stadium partnership for the rest of the 2026 season	State-level injunctions now reported in at least three states (Nevada, Massachusetts, Michigan); a browser-distribution restriction affecting 50+ tools from 1 Aug 2026; the still-pending nine-state CFTC action
Space commercialisation	Acceleration	↑ A third catalyst in ten days — Intel joining Terafab as a partner, natural-gas power plants confirmed, and a reported $60bn Cursor acquisition closing imminently — deepens both the AI-infrastructure crossover and the pace-of-news concern	28 Jul 2026	Launch cadence; constellation milestones; defence contracts; Q2 revenue/EPS/segment beats confirmed 4 Aug; the 6 Aug unlock absorbed without a selloff; the 6–7 Aug Terafab announcement and 23% two-day rally; Intel named as a third Terafab partner; the reported Cursor acquisition	A launch failure; further tranches (~21 Aug, ~10 Sep, Q3-triggered, 8 Dec) producing a delayed selling response the market has not yet shown; a funding round at a down valuation; Terafab financing disclosed as debt- or dilution-funded rather than cash-funded
Collectibles as an asset class	Decay (modern) / Saturation (vintage)	↓ Bifurcation persisting, no new information this run	28 Jul 2026	Record vintage auction results — the $16.5m Pikachu Illustrator sale in Feb still the reference point	Already firing: modern cards down 20–45%; sealed product sliding; Japanese regulation arriving
Lithium price recovery	Emergent	↓ The bearish turn continues — Elevra Lithium traded down a further 4.83% against the same supply-restart backdrop	28 Jul 2026	Elevra Lithium's June-quarter production strength (+15% QoQ, a record May month) remains on record; CME's new lithium carbonate options contract launches 17 Aug 2026	Now firing: Mineral Resources' Bald Hill restart, Core Lithium's Finniss restart and CATL's Jianxiawo permit clearance are three supply additions landing close together, alongside reports of Chinese battery-grade carbonate below CNY 145,000/t, a five-month low, and a further 4.83% Elevra share-price fall
Reimbursement as a catalyst class	Latent → Emergent	↑ A second, unrelated named example — AVITA Medical's Bell Potter upgrade cites improving Medicare Administrative Contractor reimbursement visibility as a primary driver, alongside Orthofix's already-tracked billing-code mechanism	29 Jul 2026	The CMS rulemaking calendar; code-level valuation changes; the demonstrated sub-class of unscheduled mid-cycle billing changes; now observed across two unrelated companies rather than one	Sell-side coverage arriving at the code level; the rulemaking calendar slipping; no measurable dispersion around rule publication
Australian sovereign defence capability	Acceleration	→ Holding, twelfth run without new information	29 Jul 2026	Mission Syracuse contracting through ASCA ($37.4m to date, including a June-dated US JIATF-401 tranche already folded into that figure); RfAI-3 engine unveiled; FY26 committed revenue $206m as of 28 Jul; a further A$3.2–4.6bn to the Osborne AUKUS shipyard; the 3%-of-GDP-by-2033 path	Partly firing. The company's own explanation for margin compression (hardware pass-through, currency, writedowns) is now testable against the 26 Aug segment detail, now under three weeks away
Mega-cap AI IPO wave	Acceleration	↑ A specific target date surfaced this run	31 Jul 2026	Anthropic scheduling investor roadshow meetings toward a reported 23 October 2026 Nasdaq listing target off its $65bn Series H at a $965bn post-money valuation, with bankers reportedly treating a debut above $1tn as the base case; OpenAI's own filing leaning toward 2027 per Bloomberg, with Altman holding a $1tn valuation floor	A retail-inaccessible narrative until an actual listing prices — still registered as narrative-only, not a watchlist entry, because it meets the three-independent-source bar without a tradeable small-cap expression. Kalshi's early IPO discussions (logged separately, §3) are a distinct company and are not merged into this narrative

The saturation test, live — and this is the clearest example the page has produced. When a company in a theme releases genuinely good news and the stock falls, that narrative has run out of new buyers at that price. On 28 July an ASX counter-drone pure-play reported first-half revenue up about 74%, announced roughly $23.2m of new European orders, and reaffirmed a full-year range — and fell about 10%. The market ignored the revenue line and priced two other things: a gross margin near 60% against roughly 65% a year earlier, and guidance well below published consensus. Note what this is not. It is not the story being disproven. It is the crowd having already paid for the good version. That is what Stage 3 turning into Stage 4 looks like from the inside, and it is why the narrative sits at Acceleration on this page while the sentiment cell for it reads "turning."

5 · Sentiment heatmap

Community tone as at 10 August 2026, read qualitatively across forums, social platforms and financial media. This is directional, not measured — see limitations in skills.md §9. Its purpose is crowding awareness, not prediction.

AI semis / options flow

Euphoric, turning · watchlist entry retired this week on stale score; theme now also expressed indirectly via SpaceX's Terafab entry, now with Intel named as a third partner

Quantum pure-plays

Discriminating by fundamentals · no fresh test this run; sector still down ~30% over the trailing month despite the week's snapback

ASX defence / counter-drone

Excited, turning · HY26 result still dated 26 Aug

Rare earths

Excited · Nov 10 cliff now confirmed to include the five-element second wave

Uranium / nuclear

Excited, mixed · Paladin's production ramp against a "struggling" sector headline

Prediction markets

Cautious, but pushing back · a new browser-distribution restriction lands against Polymarket's own lawsuit against New Mexico

SpaceX / space

Euphoric · a third large catalyst inside two weeks (Intel joins Terafab, Cursor acquisition reportedly closing)

ASX copper discovery

Excited · cash reserves above $45m confirmed; no new assays for a seventh day

Antimony microcaps

Cautious · still visual, thirteenth run without a fresh assay

Funded vs unfunded split

Cautious · no new test result specific to this entry's named set

Lithium recovery

Cautious, bearish turn continuing · Elevra down a further 4.83%

Reimbursement calendar

Excited, newly loud · a second unrelated name (AVITA Medical) re-rates 20% on reimbursement-clarity news

Reverse-split penny stocks

Excited, thin · 14 Aug vote now four days away

Reading the heatmap honestly

The reimbursement-calendar cell moved the most today, and moved because the pattern this page has tracked through Orthofix alone showed up in a second, unrelated name: Bell Potter's Speculative Buy upgrade of AVITA Medical, driven explicitly by improving Medicare reimbursement visibility, drove a 20.3% single-day share move — discussed in full as today's Idea of the Day (§2). SpaceX/space keeps escalating on genuine, if increasingly rapid-fire, news (Intel joining Terafab, a reported $60bn Cursor acquisition). Prediction markets moved in both directions at once — a new Chrome Web Store distribution restriction against Polymarket's own lawsuit against New Mexico — logged as a two-sided development rather than smoothed into one direction. Lithium's bearish turn continued rather than reversed.

Most other cells are effectively unchanged from last run, holding on confirming rather than new evidence: ASX defence, quantum and the funded/unfunded split all carry forward with at most a confirming detail. Rare earths and uranium both received genuine but non-directional colour (a confirmed second-wave export-control date; a mixed production/sector-sentiment signal) rather than a clean move either way. A qualitative heatmap still cannot separate "nobody is looking" from "everybody looked at one name and nobody named the pattern" — today's reimbursement move is itself an example of the pattern finally being named.

Macro overlay — a scheduling detail confirmed, no substantive change. The FOMC held at 3.50–3.75% on 29 July, a fifth consecutive hold, on a 9–3 vote with three regional Reserve Bank presidents dissenting in favour of a hike, and year-end projections spanning roughly 3.6% to 4.1%. The next scheduled decision is confirmed for 16 September 2026, with commentary describing a hike as "finely balanced" pending Middle East developments and the next two CPI prints. That is a hawkish hold, not a dovish one. Every narrative on this page is funded by the same risk appetite and that appetite has one common input, so it is worth restating: a watchlist spread across ASX explorers, US microcaps and alternative assets is not diversified across the rate path.

Reading	What it looks like	What it usually means
Fearful	Capitulation posts, "never again", volume dead	Late-stage decay; occasionally the base
Cautious	Technical questions, scepticism, small positions	Emergent — best risk/reward
Neutral	Low volume, factual discussion, little emotion	Latent or forgotten
Excited	Price targets, new accounts arriving	Acceleration — trend intact, risk rising
Euphoric	"Can't lose", leverage talk, mainstream coverage	Saturation — the marginal buyer is uninformed

The divergence patterns that matter

Volume up, price up, tone constructive → trend intact
Volume up, price flat or down, tone defensive → distribution; someone is selling into the crowd
Volume down, price up, tone quiet → accumulation, or simply illiquidity
Volume down, price down, tone hostile → decay; the story is over even if the holders aren't

6 · Risk tiers

Tiers are assigned by structure — liquidity, disclosure, cash flow, dilution history — never by price performance. A stock going up does not become safer.

Tier 1 High risk, grounded narrative

Real revenue, real assets, verifiable disclosure, adequate liquidity

Shape: profitable small caps in a hot theme, established producers, mid-cap takeover targets

Realistic downside: −50% and a slow recovery

The only tier where a merely-large position is defensible — and even then, only inside a capped speculative sleeve.

Tier 2 Very high risk, hype-driven

Listed and liquid, but valued on a story about the future

Shape: quantum pure-plays, space companies, advanced explorers, major crypto sector narratives

Realistic downside: −70% to −90% when the narrative rolls over

Small position, with the −50% plan written before entry. 30–50% swings are routine and are not signals.

Tier 3 Extreme risk, low liquidity

Thin books, wide spreads, serial dilution, minimal independent coverage

Shape: pre-resource explorers, nano-cap biotech, thinly traded shells

Realistic downside: −95%, and unable to exit at the price on screen

Assume total loss. Size it so that total loss is uninteresting. The screen price is an opinion, not an executable quote.

Tier 4 Meme-level speculation

The asset is attention itself

Shape: memecoins, pure-attention tokens, no team, no disclosure obligation

Realistic downside: −100%, quickly — and it is the base case, not the tail

Money you have already mentally spent. Nothing on this page's watchlist is Tier 4 today, and that is deliberate.

Silent tier migration is the killer. A Tier 2 company that raises twice at successive discounts and loses its liquidity has become Tier 3 without a single dramatic day on the chart. Re-tier every position monthly, on structure. This is how positions quietly become unexitable.

7 · Scoring framework

Every watchlist item is scored out of 100 across seven weighted dimensions.

Dimension	Weight	Zero points	Full points
Narrative strength	20	Company-manufactured, no external driver	Externally driven, coherent, visible in multiple unrelated sources
Catalyst strength	20	Vague, undated, immaterial	Specific, dated, material, independently verifiable
Sentiment	15	Euphoric, or completely dead	Constructive and building — not yet euphoric
Risk tier	15	Tier 4	Tier 1
Liquidity	10	Cannot exit at the screen price	Deep book, tight spread
Hype-cycle position	10	Saturation or Decay	Emergent
Information availability	10	No filings, no independent coverage	Full disclosure plus independent coverage

75–100

Genuinely interesting research subject. Still speculative; still assume the tier's downside.

55–74

Worth a written thesis and a watchlist slot.

35–54

Watch only. The narrative is real but the entry conditions are not.

0–34

Logged for pattern-learning. Not a research subject today.

The ten-minute triage

Before any deep work. Any "no" ends the analysis.

Can I name the narrative in one sentence without using the word "potential"?
Is there a specific, dated catalyst in the next 90 days?
Can I state what would prove me wrong, observably?
Is there enough liquidity that my position is a small share of daily volume?
Do primary sources exist — filings, exchange announcements, regulator publications?
Is sentiment somewhere below euphoric?
Do I know who is on the other side of this trade, and why?
Have I written the −50% plan?

What the score is not. It is not expected return, not a probability, and not a recommendation. It has not been backtested against forward returns. Its honest use is comparative and longitudinal — comparing ideas to each other today, and tracking one idea's score over time.

8 · Research routine & who to follow

The point of a routine is to make research a habit rather than a reaction to price. If you only research after something has moved, you will systematically buy late.

Daily · 15 min

Watchlist company announcements (ASX announcements platform, SEC EDGAR)
One sentiment sweep — what changed in tone, not in price
Log anything that moved >15% without news: information leaking, or a liquidity event

Weekly · 60–90 min

Narrative review: what's rising, what's gone quiet, what's become consensus
Update the 90-day catalyst calendar
Read one bear case in depth on something you hold
Cull the watchlist — a 60-name list is a list you don't read

Monthly · 2–3 hrs

Re-score every position from scratch, ignoring your entry price
Compare each score to its entry score — a falling score is your earliest exit signal
Review the journal: which reasons worked, not which tickers
Check theme concentration. Six positions in five critical-minerals stories is one position

Quarterly

Hit rate, average win vs average loss
Re-examine sizing rules against actual behaviour
Ask honestly whether the edge is real, or the market just went up

Source tiering — not all sources are equal

Each claim inherits the tier of its weakest supporting source.

Tier	What	How it may be used
A · Primary	Filings, exchange announcements, regulator publications, exchange volume data	Can support a factual claim on its own
B · Secondary	Established financial media, named analysts with disclosed positions	Can support a factual claim with attribution
C · Sentiment	Forums, social platforms, anonymous commentary	Never evidence of a fact — only evidence of what people are saying
D · Excluded	Sponsored coverage, paid research, promotional newsletters, anonymous price targets	Ignored. Their presence around an asset is itself a negative signal

Where this system looks

ASX small & microcaps

ASX company announcements, HotCopper (sentiment only), r/ASX_Bets and r/ASX, Stockhead, Proactive Investors, Livewire, Small Caps, broker note summaries.

US small & microcaps

SEC EDGAR (8-K, S-1, 424B), r/wallstreetbets and r/stocks mention trackers, Benzinga, options-flow commentary, IPO and lock-up calendars.

Alternative assets

Prediction-market volume data (Kalshi, Polymarket), collectibles indices and auction results, graded-card population reports, pre-IPO secondary commentary.

Cross-cutting

Macro and policy events that create narratives — export controls, subsidy programs, defence budgets, rate decisions, regulatory rulings.

8.2 · Who's actually worth following

People genuinely do share what they're speculating on — the problem is that the loudest channels are the worst ones. These are ranked by the source tiers above, and the honest limitation of each is stated. None of these is an endorsement of anything they recommend.

Tier A — primary. Start every serious question here.

ASX company announcements →

Free · Official · Daily

Every price-sensitive disclosure, drill result, capital raise and Appendix 5B, the moment it's lodged. This is where the news the forums are reacting to actually originates, usually hours earlier.

SEC EDGAR full-text search →

Free · Official · Real time

US filings — 8-K, S-1, prospectuses, lock-up terms. Full-text search across every filing ever made is a genuinely underused edge for retail.

ASX company directory →

Free · Official

Every listed code with its sector and listing date. Useful for building the kind of 15–20 name comparison list the Idea of the Day describes.

Tier B — reputable secondary. Good for finding what to research.

Stockhead →

Free · Daily newsletter · ASX small/microcap

The best-resourced dedicated small-cap newsroom in Australia — ex-AFR/SMH/Australian journalists covering the ~2,000 ASX companies mainstream business media ignores. Barry Fitzgerald and Tim Boreham are the names to know.

Caveat: carries sponsored articles. They are disclosed — check the top and bottom of every piece before you treat it as journalism.

Small Caps →

Free · ASX small/microcap

Broad daily coverage of ASX small and micro caps across every sector. Useful as a second read alongside Stockhead to see which stories are genuinely circulating rather than single-outlet.

Caveat: same sponsored-content model. Check disclosures.

Livewire Markets →

Free · Named fund managers

Australian fund managers writing under their own names about their actual positioning. The attribution is the value — you can see who said what, when, and hold it against them later.

Caveat: contributors talk their book by design. That's not a flaw if you read it as positioning rather than analysis.

Proactive Investors →

Free · Explorer/junior focus

Close coverage of junior explorers and their drilling programs — often the only outlet writing about a given microcap at all.

Caveat: significant paid-coverage model. Treat as a lead generator, never as evidence.

Tier C — sentiment only. Never evidence of a fact.

HotCopper →

Free · Australia's largest retail forum

The single best read on what Australian retail is actually excited about right now. Its weekly "most discussed" summary is a genuine sentiment instrument.

Caveat: structurally a room of holders. Ramping is common. Use it to measure the temperature, never to establish a fact.

r/ASX_Bets →

Free · Australian retail speculation

Faster and more self-aware than HotCopper, and more willing to post losses — which makes it a slightly less survivorship-biased read on the crowd.

Caveat: entertainment first. Position sizing advice there is not advice.

r/wallstreetbets →

Free · US retail

Mention-volume trackers built on it are the most-watched retail sentiment gauge in the US. Useful precisely as a crowding indicator — when something peaks there, it is late, not early.

Caveat: the most survivorship-biased feed on this list by a distance.

The one habit that matters most. Whatever you read on a Tier B or Tier C source, find the underlying announcement or filing before you act on it. This page learned that the expensive way: an "imminent escrow expiry" carried for three runs on forum coverage turned out, once the actual ASX substantial-holder notice was found, to be a staggered release schedule running to FY2032. The primary document said something close to the opposite of the secondary coverage. It is in the retired table above.

The decision journal

One file per position, written before entry, appended and never rewritten.

TICKER / ASSET:
Date opened:              Category and risk tier:
Position size ($ and % of speculative capital):

THE STORY IN ONE SENTENCE:

WHY NOW (the catalyst, with a date if it has one):

WHAT MUST BE TRUE (3 falsifiable points):
  1.
  2.
  3.

WHAT WOULD PROVE ME WRONG (observable, not "if it goes down"):

THE STRONGEST BEAR CASE (from someone who actually disagrees):

MY PLAN AT −50%:        (decided in advance, not "assess")
MY PLAN IF IT DOUBLES:  (decided in advance)
TIME STOP:              (a date by which the thesis must show progress)

ENTRY SCORE:  /100

--- APPEND ONLY BELOW ---
[date] Observation / score change / action taken and why

The time stop is the underrated field. Most speculative losses aren't dramatic collapses — they're slow bleeds in positions whose story quietly stopped progressing while the holder was looking elsewhere.

9 · Getting access — choosing a broker

Every ticker on this page links to its filings, not to a buy button. Here's why, and how to work out the access question for yourself.

This page deliberately doesn't link you to somewhere to buy, and doesn't name a broker it recommends. Putting a purchase link beside a scored and ranked speculative asset would make this a point of sale rather than a research tool, and would function as a recommendation to buy that specific thing — which is exactly what an educational page must not do. Broker choice also depends on your tax situation, whether you want direct legal ownership, and whether you need US market access, none of which this system knows. So the ticker chips go to the ASX announcements platform and SEC EDGAR — the primary sources this page keeps telling you to read — and the brokerage decision is set out below as criteria for you to apply.

The questions that actually decide it

1. CHESS-sponsored or custodial? — the one that matters most in Australia

A CHESS-sponsored account gives you a HIN and puts the shares in your name on the exchange's register. If the broker fails, the shares are still legally yours. A custodial account holds them in the broker's name on your behalf — cheaper, often much cheaper, but you're an unsecured creditor if the broker collapses. Custodial models are common among the low-cost app brokers. Neither is wrong; the trade is cost against counterparty risk, and for money you intend to leave in a speculative position for months it deserves a deliberate answer rather than a default.

2. What does one trade actually cost, at your trade size?

Compare brokerage on the size you'd genuinely trade, not the headline rate. A flat $5 fee is 0.5% on a $1,000 trade and 0.05% on $10,000 — and you pay it twice, on the way in and out. On a speculative position that's real drag before the thesis has done anything. Watch for percentage-based fees above a threshold, which is where "cheap" brokers stop being cheap.

3. Do you need US market access, and what's the FX spread?

Roughly half the opportunities this page tracks are US-listed. Converting AUD to USD is usually where the money quietly goes — the FX spread often costs more than the brokerage. Compare the AUD/USD conversion rate against the actual mid-market rate, both directions, and check whether the account holds USD or converts on every trade.

4. Can it even trade the thing you want?

Many microcaps sit outside the ASX 300, and some brokers restrict or surcharge them. Some won't handle rights issues or share purchase plans well — which matters, because participating in a discounted raise is one of the few structural advantages a small holder gets. Check before you need it, not during.

5. What happens at tax time?

Speculative trading generates a lot of parcels. A broker that exports a clean, complete transaction history — and tracks cost base and CGT parcels properly — saves hours and reduces the chance of an expensive mistake. Check whether it handles the CGT discount holding period and corporate actions like consolidations and demergers.

6. Is it licensed, and what protects you if it fails?

In Australia, check the entity holds an AFS licence and look it up on ASIC's registers. For offshore or app-based platforms, establish which entity you're actually contracting with and under which regulator — it's frequently not the one in the marketing. Then re-read question 1, because that's the answer to "what happens if this fails."

Where to compare, independently

ASX — find a broker →

Official · No affiliate model

The exchange's own list of participating brokers, filterable by service type. It sells nothing, so nobody paid to be at the top.

ASIC MoneySmart — choosing a broker →

Government · Independent

The regulator's own plain-English guide to broker types, fees and what protections apply. The single most conflict-free source available on this question.

A word on "best broker" comparison sites. Most run on affiliate commissions — the ranking is frequently the payout order. This isn't a conspiracy, it's just the business model, and it's usually disclosed somewhere in the footer. Read them if you like, but check the disclosure first and treat the ordering as advertising rather than analysis. The same Tier D reasoning applies here as to sponsored stock research.

10 · The six-week learning pathway

Take no real positions before Week 6. The exercises produce artefacts you keep.

Week 1

Understanding speculation

Concepts: speculation vs investing, why base rates matter, sizing arithmetic, total-loss framing.
Exercise: write your speculative capital number and per-position cap. Take zero positions.

Output: a one-page written risk policy.

Week 2

Understanding narratives

Concepts: the five lifecycle stages, manufactured vs emergent narratives, the saturation test.
Exercise: pick three live narratives from §4. Track them daily for a week — stage, evidence, who is talking, and whether good news is still moving prices.

Output: a narrative register with dated entries.

Week 3

Understanding catalysts

Concepts: the catalyst taxonomy, specificity and date certainty, sell-the-news.
Exercise: build a 90-day catalyst calendar for ten watchlist assets. Predict the direction of five in writing, then check yourself.

Output: a dated catalyst calendar and five scored predictions.

Week 4

Building a research routine

Concepts: source tiering, primary vs secondary vs sentiment, watchlist hygiene.
Exercise: run the full daily/weekly cadence from §8.1 for one week without missing a day. Cull your watchlist to twelve names.

Output: seven daily logs and one weekly review.

Week 5

Tracking sentiment

Concepts: tone vs volume, divergence patterns, crowding, reading forums as instruments.
Exercise: score sentiment daily on ten assets. At week's end, compare your scores to price action and find every divergence.

Output: your own sentiment heatmap plus a written divergence analysis.

Week 6

Evaluating opportunities

Concepts: the seven-dimension score, the ten-minute triage, the pre-mortem.
Exercise: fully score five live ideas. Write complete journal entries for the top two, including pre-mortems and −50% plans. Paper-trade both.

Output: five scorecards and two complete position journals.

Graduation test. Given any speculative idea, state within ten minutes its narrative stage, next dated catalyst, liquidity constraint, risk tier and score — then explain precisely what would make you wrong.

11 · Sandbox — simulated scenarios

Fictional teaching simulations. These are never mixed into the live watchlist. The point is to let you see a full cycle compressed into minutes, instead of learning its shape by losing money over six months.

Simulated · Scenario A

Narrative birth to death, 16 weeks

Week 0: a government announces export restrictions on a critical input. Three specialist newsletters connect it to four tickers. Latent
Week 3: forum mentions +400%, price +60%, discussion still technical. Emergent
Week 6: mainstream finance media covers the theme; two unrelated companies announce pivots into it; price +240%. Acceleration
Week 10: an ETF launches. A company posts an excellent result and closes down 4%. Saturation
Week 16: volume −70%, price −65% from peak, forum hostile. Decay

Lesson: the signal was the flat reaction to good news in Week 10 — not the price peak, which was only visible afterwards.

Simulated · Scenario B

Catalyst emergence and sell-the-news

A microcap has drill results due "in Q3." Price drifts up 80% into the window on anticipation. Results land: genuinely good grades, genuinely narrow widths. The stock closes −22%.

Lesson: the anticipation trade and the outcome trade are different positions with different exits. The result was good and the position still lost, because the anticipating buyers were the sellers.

Simulated · Scenario C

Silent tier migration

A Tier 2 pre-revenue company raises at a 20% discount, then again four months later at 30%. Share count +65%. An institutional holder exits. Average daily traded value falls 80%. No single day looks dramatic. The asset is now Tier 3 and the position cannot be exited at the screen price.

Lesson: re-tier monthly on structure. The dangerous change was invisible on the price chart.

Simulated · Scenario D

Sentiment / price divergence

Mentions rise for three straight weeks while price grinds sideways, and tone shifts from technical questions to defensive reassurance. Two weeks later, price −40%.

Lesson: rising volume with flat price and defensive tone is distribution. Someone is selling into the crowd.

Simulated · Scenario E

Regulation as a late-cycle marker

A collectibles category runs for eighteen months. Mainstream press declares it an asset class after a record sale. A regulator announces consultation on consumer protection and transparency. Prices peak within a quarter.

Lesson: regulation arrives after the crowd does. It is a stage marker, not a validation. Compare with the live collectibles narrative in §4, retired from the watchlist on 29 July once its accessible half had rolled over.

Simulated · Scenario F

The growth beat that trades like a miss

A hardware company in a well-funded policy theme reports revenue up 74% and announces new orders on the same day. Two other numbers move: gross margin falls from about 65% to about 60% as the mix shifts toward hardware sold through overseas resellers, and full-year guidance lands roughly 20% below the published analyst consensus. Short interest had been climbing for a month. The stock falls about 10% on the day.

Lesson: the crowd had already paid for the growth. Once a theme reaches Acceleration, the tradeable variable moves from "is it growing" to "against what expectation, at what margin, and who is already positioned." Note also that three of those four inputs — margin, mix, channel — are disclosed, and the fourth, consensus, is published. This scenario is drawn from a live pattern observed on 28 July 2026 and is presented here in generalised form; the live version is in §3 and §4.

12 · Traps

Structural

Illiquidity. Check average daily traded value, not market cap. If your position is a meaningful share of a day's volume, you cannot exit at the screen price.
Serial dilution. A pre-revenue company's real product is shares. Two placements a year at successive discounts means your upside is being issued to someone else.
Perpetual near-term milestones. "Results expected next quarter," every quarter, for four years. Read the old announcements.
Shell recycling. A company that was a mining explorer, then a cannabis play, then an AI play, is selling narratives — not building anything.

Social

Ramping. Coordinated promotion disguised as research: anonymous accounts, strong price targets, no falsifiable claims.
Sponsored coverage. Check the disclosure at the bottom of the article. It is always there.
The influencer's entry price. They are by definition in earlier than you, and their exit is not a public event.
Forums as due diligence. A ticker's own forum is a room of holders. Useful for sentiment, worthless for evidence.

Cognitive

Sector real ≠ company real. Rare earths matter. That says nothing about whether a specific explorer has an economic deposit.
Big market ≠ big company. "The TAM is $400bn" has preceded more losses than almost any other sentence.
Price as evidence. In a thin market, price is the opinion of whoever traded last.
Volatility as opportunity. A 40%-a-day mover isn't "active" — it's telling you the price is close to meaningless. Volatility raises the risk tier; it never raises the score.

Behavioural

Position size creep. After two wins you size up, and the third loss erases both.
Averaging down into a broken story. Only add when a falsifiable thesis point improved — never when only the price fell.
Sunk-cost narrative repair. The lithium play becomes a gold play becomes a "land bank." If the reason changed, you closed and reopened.
FOMO from screenshots. Gains get posted; losses don't. Assume every visible winner is one of ten silent losers.

The meta-trap. Believing that reading about traps immunises you against them. It doesn't. Only written pre-commitments and small position sizes do.

13 · Thematic research buckets

A market-research view of what investors, analysts and fund managers say they are watching early, across three buckets. Three sub-agents, each with its own mission, analysis, narratives, risks and conclusion. Opinions are attributed to whoever expressed them — this section summarises other people's views, it does not issue recommendations.

How to read this section. "Analysts say" and "fund managers describe" are reports of what was published, not agreement with it. Company names are examples of where a narrative is being expressed, not endorsements. Scores in the tracking tables are this system's own assessment of research interest, never forecasts of return. Full workings, sources and watchlists in ai_infrastructure.md, ai_software.md and frontier_tech.md.

Agent 1 · AI Infrastructure

Picks & shovelsSaturation

Mission: track the layer that gets paid regardless of which model or application wins — semiconductors, data-centre hardware, networking, power, cooling and manufacturing bottlenecks.

The scale investors are working with

The five largest US hyperscalers are projected to spend $660–690bn on AI infrastructure in 2026, against roughly $380bn the prior year. Some analysts frame the whole build as a ~$7 trillion capital-spending cycle and reach for the 1880s railroad boom as the comparison — usually meant bullishly, though that build also transformed the economy and bankrupted many of the companies that financed the track.

The core finding — the bottleneck moved

Through 2024–25 the binding constraint was GPU supply. Through 2026 commentary has converged on power and cooling. Global data-centre power demand is expected to rise 27% in 2026 to ~132 GW (from ~104 GW), with US demand moving 31 GW → 41 GW → 66 GW across 2025–27. Secondary bottlenecks named repeatedly: grid connection queues and skilled electrical labour — neither solved with capital alone. Morgan Stanley has framed this as energy markets racing to solve the AI power bottleneck; BlackRock has published on energy and the AI buildout.

If the constraint moved from silicon to electrons, the picks-and-shovels set moved too. Investors who mapped this trade in 2024 and haven't re-mapped it are, by their own logic, positioned in last cycle's bottleneck.

What hedge funds actually did

Per a Goldman Sachs report on Q2 2026 positioning, hedge funds entered the quarter with the highest long weight in semiconductors on record — about 10%. Biggest risers in popularity: Lam Research, Applied Materials, Analog Devices, Micron and Intel — a tilt toward semiconductor capital equipment rather than chip designers. Meanwhile software fell to ~6%, its lowest since 2019. Funds describe the strategy as building around companies with tangible order books, pricing power and capacity constraints, while shorting firms whose AI exposure is "more promotional than economic."

The counter-signal: a record 10% weight is a crowding statistic as much as a conviction one. Forbes argued on 30 July 2026 that AI stocks face a new risk as hedge-fund leverage unwinds. Both are true at once — this is where the informed money is, and that is exactly what makes the exit crowded.

A new, single company now sits inside this bucket's own narrative

SpaceX and Tesla's $16.8bn "Terafab" commitment — a Texas chip megaproject now also naming Intel as a third partner, with commentary describing a full buildout potentially reaching $119bn — is this page's clearest example yet of a company crossing from one tracked bucket into another in real time. SpaceX is tracked on the main watchlist (§3) as a float-mechanics and space-commercialisation story; Terafab pulls it directly into this bucket's own semiconductor and power narrative. SpaceX has separately confirmed it will build its own natural gas power plants to supply Terafab — a direct, if unusual, expression of this bucket's own "the bottleneck moved to power" finding, from a company this page had not previously tracked as an infrastructure name.

Must-watch early plays, as investors describe them

"The bottleneck has moved to power." Analysts argue electrical equipment, cooling and generation are earlier in re-rating than compute silicon because the market spent two years on chips. Named in commentary: Vertiv, Eaton, Trane, Constellation Energy, Bloom Energy.

"Semi cap equipment over chip designers." The logic funds give: equipment vendors are exposed to total industry capacity expansion rather than to any one architecture winning.

"Memory is the tightest link." Micron appears in both the hedge-fund popularity list and analyst picks-and-shovels lists — HBM capacity takes years, not quarters, to relieve.

"Grid connection as a moat." The less crowded framing: the scarce asset is an energisable site, not equipment. NextDC (ASX:NXT) is the ASX expression — contracted utilisation +29% to 316 MW and forward order book +53% to 205 MW by late Nov 2025, plus an announced OpenAI agreement.

Risks

A single capex cut re-rates every layer at once — diversification across layers is thinner than it looks
Crowding and leverage — record positioning is itself a risk factor
Power constraints cut both ways — if grid and labour genuinely bind, they delay revenue for everyone downstream
Depreciation — a quieter analyst debate about whether accelerator hardware's economic life matches the accounting

Conclusion. The bucket with the most real revenue and the most crowded positioning — and those facts are connected. The genuinely useful observation is that the bottleneck moved from chips to electrons while market attention moved more slowly. Against that, record semiconductor weight plus leverage-unwind commentary is Saturation behaviour on this page's own framework, not Emergent behaviour. Real order books are a floor; they are not immunity from a positioning-driven de-rating.

Agent 2 · AI Software & Models

Early monetisationEmergent

Mission: track the layer that has to eventually justify the infrastructure spend — enterprise AI, model providers, automation platforms and the data layer.

The contrarian fact that frames the bucket

Per the same Goldman Sachs Q2 2026 data, software fell to ~6% of hedge-fund long portfolios — the lowest since 2019 — at the same time semiconductors hit a record ~10%. Funds have been expressing the AI trade through hardware, not software.

The bearish read: professional money doesn't believe software captures the value — AI may compress software pricing rather than expand it.
The contrarian read: on this page's own framework, a nine-year-low positioning weight is the opposite of crowding. Emergent stages are defined by cautious sentiment and thin participation, which is exactly what a 6% weight describes.

This is the most interesting structural fact across all three buckets — the theme with the most attention (infrastructure) and the theme with the least positioning (software) sit at opposite ends of the same trade.

The monetisation evidence

OpenAI reports over 40% of revenue now comes from enterprise clients
Zylo's 2026 SaaS Management Index: AI-native application spend up 108% year over year
The SaaS delivery model for agentic AI growing at a 46.8% CAGR
Sapphire Ventures frames 2026 as "software's AI inflection point"; Vista Equity has published on the transition to agentic enterprise AI
Wedbush describes 2026 as year three of a ten-year AI cycle with "transformational" monetisation ahead

The mechanism that matters — pricing

Pricing is moving from "pay for access" to "pay for work done." Seat-based SaaS caps revenue at the number of humans a customer employs; outcome pricing uncaps it — but only for vendors who can measure the work an agent performed and bill for it. Commentary names Salesforce, ServiceNow, Intercom and HubSpot as demonstrating that agents can expand the addressable market rather than cannibalise it.

The checkable test this implies: in the next results, is AI revenue disclosed as a separate, growing line item with retention attached — or described qualitatively in the CEO letter? That distinction separates the two halves of this bucket better than any valuation screen.

The counter-narrative — the ROI reckoning

Enterprise AI is described as hitting an inflection point as companies rein in spending and demand real results, with commentary referencing an enterprise AI "ROI crisis" — large aggregate spend against thin demonstrated returns, and procurement getting more stringent as pilots move from innovation budgets to operating budgets. Both things are happening at once: AI-native spend up 108%, and buyers getting harder to sell to. The reconciliation most analysts reach is consolidation — spend growing but concentrating into fewer vendors who can prove outcomes. That makes this a discrimination trade rather than a theme trade.

The two named comparisons

Palantir (PLTR). Analysts expect earnings growth of ~95% in 2026 and ~42% in 2027 against roughly 65x forward earnings; consensus is a "Moderate Buy" with 19 of 28 analysts at "Strong Buy." Bull case: defence and government contracts plus genuine deployed-AI revenue. Bear case: the valuation already prices several years of that growth, leaving no room for a miss.

Snowflake (SNOW). Expanded a $6bn five-year AWS agreement focused on generative and agentic AI. The structural contrast analysts draw is useful: Palantir's model involves significant upfront customisation, while Snowflake and Databricks run consumption-based models — more sensitive to a slowdown, faster-scaling in an upswing.

A structural note: the two most important model providers — OpenAI and Anthropic — are private. The purest exposure to this bucket cannot be bought on an exchange, which pushes public money into adjacent layers.

Risks

The ROI reckoning resolving badly — software budgets are far more cancellable than data-centre contracts
Price compression — AI may make software cheaper to build, inviting competition into every category at once
Consumption models cut in reverse — usage pricing de-scales as fast as it scales
Positioning risk in reverse — a 6% weight is thin support; under-owned assets fall further on bad news because there is no marginal buyer

Conclusion. The mirror image of AI Infrastructure. Fundamentals and positioning are diverging — and divergence is where this page's framework says to look. The caution is equally real: the ROI reckoning is a serious argument, not a bear-case formality. The most defensible read is a discrimination trade, with a widening gap between vendors who can prove outcomes and everyone else. ASX note: there is little genuine ASX exposure to this bucket. WiseTech and TechnologyOne are quality software businesses whose AI linkage is applied rather than native — forcing an ASX name in here would be a worse answer than admitting the gap.

Agent 3 · Frontier Tech / EV / Energy

High-risk early stage

Mission: track where the technology is real, the timeline is long, and the gap between narrative and revenue is widest — EVs, autonomy, batteries, energy systems, biotech and moonshots.

The discipline applied throughout is this page's test for a thematic hype cycle: is the revenue in the theme, or only the narrative? Here the honest answer is usually "not yet" — so the work is separating the categories where that is changing from those where it isn't.

Autonomy — the category that actually crossed over

CES 2026 commentary describes robotaxis "graduating from concept showcases to real-world testing and commercial operation." The reference deployment: Uber, Lucid Motors and autonomy specialist Nuro — a Lucid Gravity SUV built for Level 4 autonomy, seating six, 450-mile range, with commercial rollout in San Francisco later in 2026.

Why this scores highest in the bucket: it is a dated, verifiable event with multiple disclosing parties, and it converts autonomy from a capability question into a unit-economics question analysts can model. The risk analysts name most: robotaxi timelines have slipped for a decade, and one high-profile safety incident has historically reset the whole category's regulatory clock regardless of who caused it.

Weekly update — the category keeps moving, and the competitive structure is starting to fracture. Uber is reportedly targeting autonomous ride-hailing operations in 15 cities by the end of 2026, while Tesla's own Robotaxi network has crossed 380,000 unsupervised miles and expanded into Miami, Orlando and Tampa. More consequential for how this category is structured: TechCrunch reports Waymo is exploring an exit from its Uber operating deal, intending to launch independently — its own app, its own markets — in Austin and Atlanta once its contract permits in January 2028, after what is described as a deteriorating relationship over service quality and routing disputes. A single-partner robotaxi ecosystem was always a simpler story to model than a multi-operator one; this is early evidence the category is fragmenting rather than consolidating around one distribution model, which cuts against any single listed name capturing the whole trade.

Solid-state batteries — real progress, wrong end market for the popular story

Donut Lab (Finland) unveiled what it claims is the first production-ready all-solid-state vehicle battery, shipping to OEM partners from early 2026. EVE Energy is delivering 100 MWh of annual capacity for its 10Ah all-solid-state cell by December 2026 — aimed at humanoid robots, low-altitude aircraft and AI devices. The listed expression investors track is the Solid Power vs QuantumScape race.

The tell: EVE targeting robots and aircraft rather than passenger EVs means early solid-state capacity is going where energy density matters more than cost. First revenue lands in niches, not the mass EV market the narrative is usually sold on. Anyone modelling this as an EV story is modelling the wrong end market first.

This links mechanically to humanoids: mobile robotics on current lithium-ion typically achieve 1–4 hours of operation, with battery weight at 20–40% of system mass. That is the constraint solid-state has to solve.

Humanoid robotics — the widest narrative-to-revenue gap

Analysts describe 2026 as "the decade of the robot", with the humanoid market projected to grow from $2–3bn today to $200bn by 2035, and Wall Street commentary calling it potentially one of the biggest opportunities in the AI revolution. Robotics startups hit record venture funding in 2026.

The correcting observation, and the most useful fact in this bucket: as of July 2026 humanoid robotics looks more like a scaling market than a seed-formation market. Visible funding is dominated by follow-on rounds to companies that already cleared earlier screens — a concentrated race among a limited set of credible platforms, not a wide formation market.

That inverts the retail framing. "Early-stage opportunity" implies a wide field where picking well pays. A concentrated follow-on market means the winners are largely already identified and privately funded — so listed "early exposure" is often exposure to suppliers or to narrative, not to the platforms. Government programmes (France 2030, Korea's K-Robotics, Japan's Moonshot R&D) are now material co-investors, which extends runways and reduces the odds of a clean shakeout.

Confirming, not new, this run: the supplier thesis picked up fresh evidence rather than a reversal — The Motley Fool describes Wall Street as seeing a multitrillion-dollar humanoid robot market with component suppliers as the accessible listed expression, naming TE Connectivity and Regal Rexnord as suppliers of connectors, sensors and actuator components to humanoid developers, while a broader robotics rally saw Vishay Precision Group up roughly 140% year-to-date on its precision-sensor exposure. This is the same "exposure to suppliers, not platforms" argument made two paragraphs above, now with three additional named examples rather than a change of view.

AI biotech — a genuinely new, countable metric

The first AI-derived drugs entered trials as of 2025, with Vertex working with Recursion on an AI-derived small molecule. Analysts now track "AI-derived candidates in clinical pipeline" as a trend indicator. The emergence of a countable metric is what separates this from the rest of the bucket — it converts an unfalsifiable story into a scoreboard with dated, binary readouts. The offset: a readout is "a coin flip with a schedule", and AI provenance provides no protection when one fails.

ASX exposure — genuine here, unlike AI software

Uranium developers ASX:BOE ASX:PDN ASX:DYL ASX:BMN, battery feedstock ASX:ELV ASX:LTR ASX:PLS, and defence adjacency ASX:DRO ASX:EOS. Worth stating plainly: DroneShield is a counter-drone company, not an AI data-centre or uranium play, despite appearing in loosely assembled "ASX AI" lists. The honest characterisation is that the ASX offers input exposure to frontier tech — the minerals and components — rather than the frontier technologies themselves.

Risks

Timeline slippage is the base case — every category here has a documented history of milestones moving right
A single safety incident is a category-level risk in autonomy, not a company-level one
Funding-winter exposure — pre-revenue frontier companies need continuous capital; dilution is the quiet mechanism
Correlation with the AI trade — this bucket runs on the same risk appetite with the least revenue to absorb a reversal

Conclusion. Autonomy has crossed over — a dated commercial rollout with multiple disclosing parties is the strongest catalyst structure here by a distance. AI biotech has acquired a scoreboard. Solid-state is progressing, but into niches rather than the mass EV market the story is sold on. Humanoid robotics is the one to be most careful with, precisely because the commentary is most enthusiastic: the phrase "early-stage opportunity" is doing misleading work when the credible platforms are already identified and privately funded.

14 · Cross-bucket risk tiering

The same three buckets, re-cut by risk rather than by theme. Tiers are assigned on structure — balance sheet, revenue durability, liquidity, dilution history — never on price performance. "Low risk" is relative to the others on this page, not to a term deposit.

Low risk (relative)

Strong balance sheets, recurring revenue or dominant positions

Infra: large-cap compute and networking incumbents; diversified industrials with data-centre segments (Eaton, Trane) — fund commentary favours these because the non-AI business provides a floor; semi cap equipment majors

Software: big-tech platforms where AI is upside on an already-profitable base — Wedbush's view of big tech as the main monetisation beneficiary sits here; established data-layer names

Frontier: diversified energy and utility exposure to AI power demand, where the frontier narrative is optionality rather than the whole thesis

The honest catch: hedge-fund semiconductor weight at a record ~10% means the "safe" end of the infra bucket is also the most crowded. Positioning risk is not business risk, and this tier carries more of the former than its balance sheets suggest.

Medium risk

Strong growth with meaningful competition or volatility

Infra: Micron — genuine memory tightness, but memory is historically the most cyclical corner of semis; Vertiv and Bloom Energy on the power narrative; Super Micro and Jabil on thin assembly margins; CoreWeave on customer concentration and buildout debt; NextDC and Macquarie Technology, capital-intensive with grid dependency

Software: Palantir — the risk is almost entirely in the multiple rather than the business; agentic workflow platforms where the open question is whether agents expand or erode the seat model; observability names exposed to consumption slowdown

Frontier: established EV makers with autonomy programmes; uranium developers with defined resources and funding; grid-scale storage; platform biotech with a named partner — Recursion given the Vertex collaboration

Analysts describe this tier as where the work pays: real businesses with a genuinely contested outcome, rather than a story or a certainty.

High risk

Early-stage, frontier or moonshot

Infra: small-cap power, grid and cooling suppliers — the "next Vertiv" search, where coverage is thin and promotional material is common; pre-revenue generation including SMR developers

Software: pure-play AI application companies with thin revenue — exactly the profile procurement is now selecting against; private model providers accessed via secondaries, where fee layers are heavy and pricing opaque

Frontier: solid-state developers valued on a manufacturing scale-up that has repeatedly taken longer than announced; listed humanoid exposure that is usually a supplier proxy; pre-revenue autonomy specialists, binary on approval and safety record

The category that spans all three: anything whose AI exposure is announced rather than contracted — precisely what hedge-fund commentary describes shorting. And anything described as a moonshot with no dated milestone: positions held against "soon" are where speculative capital dies quietly.

15 · Speculation-tracking system

A repeatable system for tracking thematic speculation: seven categories, seven fields per entry, five scan cadences, and a machine-readable register. Full specification in tracking_system.md; the register itself is schema.json.

Tracking fields

Narrative strength 1–5

How coherent, externally driven and multi-sourced the story is. 5 = driven by policy, physics or verified demand across unrelated sources. 1 = a ticker in search of a story.

Analyst sentiment 1–5

What published, named analysts say. Attribution required. 2 or below where coverage is thin or largely sponsored.

Hedge-fund interest 1–5

Positioning from 13F, prime brokerage and fund commentary. Read both ways: 5 means informed agreement and a crowded exit; 1 with a high narrative score is what Emergent looks like.

Catalyst timeline

The next dated event and its date. If none exists, write "Undated" — never "soon" or "H2". Undated is a red flag, not a neutral value.

Risk tier

Low / Medium / High / Extreme, mapped to the four tiers in §6. Assigned on structure, never on price performance.

Volatility profile

Low → Very high. Records observed behaviour so a 30% move can be read as normal or abnormal. Volatility raises the tier; it never raises the score.

Theme alignment

The test: if the theme plays out exactly as described, does this entity capture value? Rare earths mattering says nothing about whether one explorer has an economic deposit.

Update workflow

Daily

News scan across all seven categories with the 06:30 run. Update catalyst dates, flag narratives contradicted by a primary source, log new entrants. A quiet day is a valid result.

Weekly · Mon

Earnings and catalyst scan. Roll the 90-day calendar, record resolved catalysts and their reaction, apply the saturation test — did good news produce a flat close?

Monthly · 1st

Hedge-fund sentiment scan. Update positioning from the latest 13F and fund commentary, noting extremes in both directions. Re-tier anything whose structure changed.

Quarterly

Narrative re-evaluation after reporting season. Re-place every narrative on the lifecycle, retire what reached Decay, review the register's own hit rate — which reasons worked, not which tickers.

Annual · Jan

Theme realignment. Ask whether the seven categories still describe the market — the AI Infrastructure/Software split is a 2025–26 distinction and won't stay useful forever.

On 13F data: filings are quarterly and lag roughly 45 days — Q2 2026 filings were due 14 August 2026. Treat positioning as a photograph of the past, not the present.

The register

Company / theme	Category	Narr.	Analyst	HF	Catalyst timeline	Risk	Vol.	Theme alignment
Power & thermal suppliers VRT ETN TT	AI Infrastructure	5	4	4	Q3 earnings, Aug–Sep 2026	Low–Med	Medium	Very high — binding constraint
Semi cap equipment LRCX AMAT ASML	AI Infrastructure	4	4	5	Q3 earnings; capex guidance	Low	High	High — total capacity exposure
Memory MU	AI Infrastructure	4	4	5	Quarterly; HBM pricing	Medium	High	High but cyclical
Grid-connected DC operators ASX:NXT ASX:MAQ ASX:MP1	AI Infrastructure	4	4	2	Contracted-utilisation updates	Medium	Medium	High — energisable sites
Enterprise data layer SNOW MDB	AI Software	4	4	2	Quarterly consumption metrics	Low–Med	High	Very high — durable toll booth
Applied AI PLTR	AI Software	5	4	3	Quarterly; contract news	Medium	Very high	High — multiple is the risk
"Software is under-owned" Contrarian Positioning thesis, no single ticker	AI Software	3	2	1	Dated — Q3 13F, 14 Nov 2026	Medium	High	Very high if it re-rates
Robotaxi commercialisation UBER LCID	EV / Autonomy	5	4	3	Dated — SF rollout later 2026	Med–High	High	Very high
Solid-state batteries SLDP QS	Energy Storage	4	2	2	OEM qualification; EVE Dec 2026	High	Very high	High — niche end market first
Uranium developers ASX:BOE ASX:PDN ASX:DYL ASX:BMN	Energy Storage	4	3	2	Undated — utility contracting	Medium	High	Very high — AI crossover
AI drug discovery RXRX VRTX	Biotech	4	3	2	Trial readouts — dated, binary	High	Very high	Very high — countable metric
Humanoid robotics exposure No clean listed platform exposure	Moonshots	5	3	2	Undated — platform milestones	High	Very high	Medium — supplier/narrative proxy

Full register with attributions, source tiers and validation rules: schema.json · 12 entries, 25 verified ticker links, every narrative claim carries an attribution string.

JSON schema for automation

The register is machine-readable so the daily run can update it programmatically. Validation rules that matter:

The three scored fields must be integers 1–5
If catalyst.dated is false, catalyst.date must be null — no fudging an undated event into a timeframe
Every narrative claim requires an attribution string. A claim supported only by a Tier C source is invalid as evidence of fact
filings_url must point at an exchange announcements page or a regulator's filing system — broker, trading-platform, affiliate and purchase URLs fail validation anywhere in the file

16 · Investor sentiment tables

Nine tables — three per agent — summarising public investor chatter, analyst commentary and institutional positioning. Every framing is attributed to the group that expressed it. Markdown versions live in the three agent files; a clean copy-paste HTML version of all nine is in tables.html — semantic tags only, no inline styles, no scripts, no dependencies.

Risk Level maps to the four-tier structural scale in §6 and is assigned on balance sheet, liquidity and disclosure — never on price performance. "Speculative", "Long-hold" and "Solid" describe how each group of market participants is behaving, not a suggested holding period. Company names are examples of where a narrative is being expressed.

Agent 1 · AI Infrastructure

Speculative Picks (Investor Chatter)

Company	Sector	Why Investors Talk About It	Common Narrative	Risk Level
CoreWeave	AI Infrastructure	AI-native cloud scaling faster than incumbents, with very large contracts announced	"Investors often describe it as the purest listed proxy for GPU demand, while flagging customer concentration and the debt funding the buildout"	High
Bloom Energy	AI Infrastructure / Energy	On-site fuel cells pitched as a way around grid-connection queues	"Investors often view off-grid generation as the workaround for data centres that cannot get an energisation date"	High
Super Micro (SMCI)	AI Infrastructure	Direct rack and server exposure to hyperscaler capex	"Investors often frame it as maximum torque to the buildout, with commentary repeatedly noting thin assembly margins"	High
Small-cap power and cooling suppliers	AI Infrastructure	The "next Vertiv" search — thermal and electrical names with little coverage	"Investors often say the power bottleneck has not yet been priced into the smaller suppliers"	High
SMR and advanced nuclear developers	Energy Storage	Data-centre baseload demand attached to a pre-revenue technology	"Investors often describe nuclear as the only baseload answer at AI scale, while conceding revenue sits in the 2030s"	High
SpaceX (Terafab joint venture)	AI Infrastructure / Semiconductors	A $16.8bn Texas chip megaproject with Tesla and Intel, announced alongside an already-euphoric float-unlock rally	"Coverage describes it as turning a space-launch and satellite story into a chip-manufacturing one overnight, with commentary flagging the financing structure as the open question"	High

Long-Hold Picks (Analyst Narratives)

Company	Sector	Analyst Commentary	Strengths	Risk Level
Eaton (ETN)	Electrical equipment	"Analysts commonly highlight the electrical systems that deliver and manage data-centre power as a direct beneficiary of the shift from chip to power constraints"	Diversified industrial base outside AI; established order book; pricing power	Medium
Trane Technologies (TT)	Cooling / HVAC	"Analysts commonly highlight thermal management as a defining constraint in AI deployment"	Specialised cooling installed base; non-AI revenue provides a floor	Medium
Vertiv (VRT)	Power & thermal	"Analysts frequently place it in the first tier of infrastructure suppliers named alongside NVDA, SMCI, CEG and ANET"	Direct exposure to both binding constraints; growing order book	Medium
Arista Networks (ANET)	Networking	"Analysts commonly describe switching fabric as unavoidable spend regardless of which accelerator wins"	Entrenched hyperscaler relationships; high margins	Medium
NextDC ASX:NXT	Data centres	"Analysts note contracted utilisation grew 29% to 316 MW with the forward order book up 53% to 205 MW, and that operators holding secured grid connections have a structural advantage"	Australia's largest independent operator; announced OpenAI agreement; secured connections	Medium

Solid Picks (Institutional Interest)

Company	Sector	Institutional Behaviour	Why Funds Accumulate	Risk Level
Lam Research LRCX	Semi cap equipment	"Per Goldman Sachs data on Q2 2026 positioning, it was among the biggest risers in hedge-fund popularity"	Exposure to total industry capacity expansion rather than to any one architecture winning	Low
Applied Materials AMAT	Semi cap equipment	"Named alongside Lam Research among the largest increases in hedge-fund popularity in Q2 2026"	Toolmakers get paid on every fab expansion regardless of end customer	Low
Micron MU	Memory	"Appears in both the Q2 2026 hedge-fund popularity list and analyst picks-and-shovels lists"	High-bandwidth memory described as capacity-constrained on a multi-year, not multi-quarter, horizon	Medium
Nvidia NVDA	Compute silicon	"Hedge funds entered Q2 2026 with a record ~10% long portfolio weight in semiconductors, with Nvidia among the most commonly disclosed holdings"	Funds describe building around companies with tangible order books, pricing power and capacity constraints	Medium
Broadcom AVGO	Compute silicon / networking	"Consistently disclosed across AI-linked infrastructure exposure in Q2 2026 filings"	Custom accelerator and networking exposure diversifies away from merchant GPU competition	Medium

Agent 2 · AI Software

Speculative Picks (Investor Chatter)

Company	Sector	Why Investors Talk About It	Common Narrative	Risk Level
Palantir PLTR	Applied AI	Government and enterprise AI contracts against a demanding multiple	"Investors often say it is the only company actually deploying AI into workflows at scale; sceptics reply that ~65x forward earnings prices several years of that in advance"	High
Private model providers via secondaries	Model providers	OpenAI and Anthropic are unlisted, so exposure is sought through feeder structures	"Investors often note the purest exposure to this bucket cannot be bought on an exchange, and that access vehicles carry heavy fee layers"	High
Thin-revenue AI application pure-plays	AI Software	Narrative exposure without disclosed AI revenue	"Hedge-fund commentary describes shorting firms whose AI exposure is more promotional than economic"	High
The "software is under-owned" thesis	AI Software	Positioning and fundamentals pointing in opposite directions	"Investors making this argument note software fell to ~6% of hedge-fund portfolios, the lowest since 2019, while AI-native application spend rose 108% year over year"	Medium

Long-Hold Picks (Analyst Narratives)

Company	Sector	Analyst Commentary	Strengths	Risk Level
Snowflake SNOW	Data layer	"Analysts commonly highlight the expanded $6bn five-year AWS agreement focused on generative and agentic AI infrastructure"	Consumption model scales with usage; data gravity is hard to displace	Medium
MongoDB MDB	Data layer	"Analysts group it with Palantir and Snowflake as a leading AI software name, tied to modern AI application development"	Developer adoption; positioned where AI applications are actually built	Medium
ServiceNow NOW	Agentic workflow	"Analysts cite it among vendors proving AI agents can expand the addressable market rather than shrink it"	Entrenched enterprise workflow position; pricing shifting toward work performed	Medium
Salesforce CRM	Agentic workflow	"Named alongside ServiceNow, Intercom and HubSpot as demonstrating agent monetisation"	Large installed base to upsell agents into; established enterprise relationships	Medium
Microsoft MSFT	Platform	"Wedbush expects 2026 to be the third year of a ten-year AI cycle with US big tech as the main beneficiaries of the monetisation inflection"	AI is upside on an already-profitable base rather than the entire thesis	Low

Solid Picks (Institutional Interest)

Company	Sector	Institutional Behaviour	Why Funds Accumulate	Risk Level
Microsoft MSFT	Platform	"Remains among the largest and most consistently disclosed institutional positions"	Funds describe it as owning both the infrastructure and the distribution for enterprise AI	Low
Alphabet GOOGL	Platform	"Major hedge-fund positions remain concentrated in Amazon, Nvidia, Alphabet, Microsoft and Meta"	Owns models, cloud and distribution simultaneously; internal silicon reduces supplier dependence	Low
Amazon AMZN	Platform / cloud	"Consistently among the largest disclosed institutional holdings; also took the top spot in retail investors' most-upvoted picks for 2026"	AWS captures AI workloads regardless of which model provider wins	Low
Oracle ORCL	Cloud infrastructure	"Disclosed across AI-linked infrastructure exposure in Q2 2026 filings"	Contracted AI cloud backlog gives funds a visible order book	Medium

Reading these three tables together. The Solid Picks table is populated almost entirely by platform incumbents, while the pure-play software names sit in Speculative. That is not an accident of selection — it is the ~6% hedge-fund software weight showing up in table form. Funds are taking AI software exposure through companies where AI is upside on an existing profit base, not through companies where AI is the business.

Agent 3 · Frontier Tech

Speculative Picks (Investor Chatter)

Company	Sector	Why Investors Talk About It	Common Narrative	Risk Level
QuantumScape QS	Energy Storage	Solid-state battery development against a contested commercialisation timeline	"Investors often frame the Solid Power versus QuantumScape race as the listed expression of who reaches solid-state first"	High
Solid Power SLDP	Energy Storage	OEM partnerships attached to a pre-revenue manufacturing scale-up	"Investors often describe solid-state as the holy grail of energy storage, while noting timelines have repeatedly moved right"	High
Humanoid robotics exposure	Moonshots	Projected growth from $2–3bn today to $200bn by 2035	"Analysts describe 2026 as the decade of the robot; funding analysis notes it is now a concentrated scaling market rather than a wide seed-formation market, so listed exposure is often to suppliers rather than platforms"	High
Recursion RXRX	Biotech	AI-derived candidates entering clinical trials with a named large-cap partner	"Analysts now track AI-derived candidates in clinical pipeline as a trend indicator; readouts remain binary"	High
Lucid Motors LCID	EV / Autonomy	Robotaxi platform with Uber and Nuro, targeting a dated commercial rollout	"Investors often point to the Level 4 Lucid Gravity robotaxi with a 450-mile range and San Francisco rollout later in 2026 as the category's proof-of-concept moment"	High
Vishay Precision Group VPG	Moonshots / robotics supply chain	Precision sensor supplier riding the humanoid-robotics build-out	"Coverage attributes the stock's roughly 140% year-to-date move to precision-sensor exposure sold into humanoid robotics developers, the supplier framing analysts favour over betting on any single platform"	High

Long-Hold Picks (Analyst Narratives)

Company	Sector	Analyst Commentary	Strengths	Risk Level
Uber UBER	EV / Autonomy	"Analysts describe robotaxis as graduating from concept showcases to real-world testing and commercial operation, with the Uber–Lucid–Nuro vehicle as the reference deployment; Uber is reportedly targeting operations in 15 cities by the end of 2026"	Existing demand network; autonomy is optionality on a profitable base rather than the whole thesis	Medium
Constellation Energy CEG	Energy / generation	"Analysts place it in the first tier of infrastructure beneficiaries as data-centre power demand rises 27% in 2026 to about 132 GW"	Real generation assets and contracted revenue; sits in both the AI-power and decarbonisation narratives	Medium
Paladin Energy ASX:PDN	Energy Storage / uranium	"Citi analysts have projected uranium moving from around US$84–86/lb in June 2026 to US$100–125/lb through the rest of the year"	Producing asset with defined resource; leveraged to a contracted-price cycle	Medium
Boss Energy ASX:BOE	Energy Storage / uranium	"Commentary links uranium demand directly to data-centre baseload requirements"	Australian production base; exposure to utility contracting rounds	Medium
Vertex Pharmaceuticals VRTX	Biotech	"Analysts note Vertex is working with Recursion on an AI-derived small molecule, among the first AI-derived drugs to enter trials"	Profitable commercial base; AI discovery is optionality rather than the core thesis	Low

Solid Picks (Institutional Interest)

Company	Sector	Institutional Behaviour	Why Funds Accumulate	Risk Level
Constellation Energy CEG	Energy / generation	"Hedge funds are identifying power and utility providers as central to the AI investment thesis, with commentary describing data centres as the new hedge-fund battleground"	Funds favour tangible order books and capacity constraints — generation capacity is both	Medium
Bloom Energy BE	Energy / generation	"Disclosed across AI-linked infrastructure exposure in Q2 2026 filings alongside Nvidia, AMD, Oracle and CoreWeave"	On-site generation positioned against grid-connection queues named as a primary bottleneck	Medium
Vertex Pharmaceuticals VRTX	Biotech	"Institutional biotech allocations favour companies with commercial revenue funding discovery-stage risk"	Cash-generative base absorbs the failure rate inherent in clinical readouts	Low
Uber UBER	EV / Autonomy	"Institutional interest focuses on platforms with existing demand that can add autonomy, rather than on autonomy developers seeking demand"	Autonomy improves unit economics on an existing network instead of requiring one to be built	Medium
Diversified industrials with robotics divisions	Moonshots / robotics	"Analysts describe these as the conservative expression of the humanoid theme"	Robotics upside on a profitable base; avoids the concentrated private-platform access problem	Low

Reading these three tables together. Every name in the Frontier Solid Picks table reaches this bucket through an existing profitable business — generation assets, a commercial drug portfolio, a ride-hailing network. None of the pure frontier technologies appear there. Institutional money is taking frontier exposure as optionality on a cash-generative base, which is a different trade from the one the Speculative table describes.

17 · Jargon index

Every piece of jargon used on this page and across the documentation, in plain English. Type to filter. Tags mark where a term is mostly used: core concepts, ASX, US, alt assets, behaviour.

124 terms

A B C D E F G H I J L M N O P Q R S T U V W

AFS licencecore

Australian Financial Services licence — the authorisation a broker or adviser must hold to operate here, searchable on ASIC's registers. For an offshore or app-based platform, establish which entity you're actually contracting with and under which regulator; it's often not the one in the marketing.

Accelerationcore

Stage 3 of the narrative lifecycle. Mainstream media has picked the theme up, new listings and capital raisings appear to serve demand, and prices go vertical. The trend is intact but the risk is rising fast.

Accumulationcore

Buying that happens quietly, without the price running away. On this page it describes the pattern of falling discussion volume with a rising price — someone is building a position without attracting a crowd. The opposite of distribution.

ADTV — average daily traded valuecore

The typical dollar value of a stock traded per day. This, not market cap, is the real constraint on your position size. If your intended position is a meaningful share of a day's ADTV, you cannot get out at the price on the screen.

Appendix 5BASX

The quarterly cashflow report that ASX-listed exploration companies must lodge. It discloses cash on hand and quarterly spending. Cash divided by burn gives you quarters of runway — the single most useful number for predicting a dilutive capital raise.

AUKUSASX

The Australia–UK–US security partnership, whose submarine and advanced-capability programs are the largest driver of Australia's rising defence budget. It generates narratives for local suppliers but names a category of spending, not an amount attributable to any one small-cap — the individual contracts announced under it are typically small relative to the headline program cost.

Averaging downbehaviour

Buying more of a falling position to reduce your average entry price. Defensible only when a falsifiable part of your thesis actually improved. Doing it because the price fell is how small losses become large ones.

Brokeragecore

The fee per trade. Judge it as a percentage of the size you actually trade, and remember you pay it twice — entering and exiting. A flat $5 is 0.5% on a $1,000 trade, which is real drag before the thesis has done anything.

Base ratecore

The underlying frequency of an outcome across all similar cases. The base rate for speculative positions is that most lose money. Any process that assumes a high hit rate is ignoring its own base rate.

Bear casecore

The strongest argument that you are wrong. To be useful it must come from someone who actually disagrees — writing your own weak version of it is a way of feeling rigorous without being rigorous.

Bifurcationcore

When one market splits into two that behave differently. The 2026 collectibles market is the clean example: vintage cards setting records while modern cards fall 20–45%. A headline index number averages the two and tells you nothing, which is why "the market is up" is often a statement about weighting rather than about the thing you own.

Burn ratecore

How fast a company spends cash, usually per quarter. Combined with cash on hand it tells you how long the company can operate before it must raise money, sell something, or stop.

CHESS sponsorshipASX

Holding ASX shares under your own HIN, registered in your name on the exchange's register. If the broker fails, the shares are still legally yours. The alternative is a custodial account — cheaper, but you're an unsecured creditor if the broker collapses.

Custodial accountASX

A broker holds shares in its own name on your behalf rather than registering them to you. Common among low-cost app brokers. The trade is lower cost against counterparty risk — worth a deliberate decision for money sitting in a position for months.

Capital raising / placementASX

A company issuing new shares for cash, usually to institutions at a discount to the market price. The most common cause of a sudden price drop with "no news." Every raise dilutes existing holders.

Catalystcore

A specific event that forces the market to re-price an asset. "Sector momentum" is not a catalyst; it's an excuse. Good catalysts are specific, dated, material and independently verifiable.

CFTCalt

The US Commodity Futures Trading Commission. It regulates the legal American prediction-market exchanges such as Kalshi, which is what separates them from offshore betting platforms.

CHIPS ActUS

US legislation directing federal funding into domestic semiconductor and advanced-technology manufacturing. Its funding announcements have repeatedly acted as policy catalysts, including the $2bn quantum allocation in May 2026.

Class II / Class III deviceUS

The FDA's risk-based classification of medical devices, where Class III carries the heaviest premarket burden and Class II the lighter one. A reclassification is normally read as a regulatory easing, but it can cascade: the April 2026 move of non-invasive bone growth stimulators from Class III to Class II preceded a May change to how they were billed to Medicare, which was then reversed on 1 July. A classification change can therefore reach revenue by a route that has nothing to do with clinical approval.

Comment period (rulemaking)US

The window in which the public may formally respond to a proposed government rule before it is finalised. It is a deadline for input, not a resolution — which is exactly why a proposed rule is weaker evidence than it looks. The CY2027 Medicare fee schedule comment period closes 14 September 2026.

Committed revenueASX

Revenue a company has contracted but not yet recognised — signed orders plus, sometimes, expected subscription income. It is a useful forward indicator and a favourite of companies whose reported revenue is lumpy. Two cautions: committed revenue says nothing about the margin that revenue will carry, and the portion attributed to future subscription periods is a company estimate, not a contracted certainty.

Confirmation biasbehaviour

Seeking and believing information that supports what you already think. In speculation it usually shows up as reading only a ticker's own forum, where every participant is a holder.

Consensus estimatecore

The average of covering analysts' forecasts for a company's revenue or earnings. It matters less as a prediction than as a reference point: a result is judged good or bad against consensus, not against last year, which is why a company can grow revenue 74% and fall on the day. For thinly covered small caps the consensus may rest on two or three forecasts, making it fragile as a benchmark and dangerous as a target.

Continuous disclosureASX

The legal obligation on listed companies to tell the market promptly about anything that would materially affect their share price. It's why primary research on listed microcaps is possible at all.

Conversion factorUS

The single dollar multiplier CMS applies to every procedure's relative value units to produce a Medicare payment. It is the number the press reports, and usually the least informative part of a fee-schedule rule — a 1.2% trim is noise for most businesses, while a change to one code's relative value units can be the whole investment case for a small one.

CPT / HCPCS codeUS

The standardised billing codes used to charge for medical procedures and products in the United States. For a small-cap device or diagnostics company, one code can carry effectively all the revenue — which makes a regulator's rate table more load-bearing than the company's own forecasts.

Critical mineralsASX

Minerals a government deems essential to its economy or defence and vulnerable to supply disruption — rare earths, antimony, lithium, cobalt, uranium and others. The designation itself creates narratives, because it precedes subsidies and trade restrictions.

Crowdingcore

How many people are already in the same trade. A crowded position has less upside left and a more violent exit, because everyone reaches for the door at the same moment. Twelve holdings in crowded themes is one position, not twelve.

DCM — designated contract marketalt

A CFTC-registered US futures exchange, the licence under which legal American prediction markets operate. DCMs may self-certify new products rather than seek prior approval, which is what allowed thousands of event contracts to launch quickly — and is why a CFTC advisory narrowing that process is a bigger deal for the sector's growth rate than any single court ruling.

De minimis rule (0.1%)core

An export-control provision capturing foreign-made goods that contain more than a trivial proportion of controlled content — in China's October 2025 rare-earth rules, 0.1% by value. Its significance is reach: a 0.1% threshold pulls products made entirely outside the country into the licensing regime. Suspended until 10 November 2026.

Decaycore

Stage 5 of the narrative lifecycle. The story isn't disproven — it gets boring. Volume falls first, price follows, and the remaining forum discussion turns hostile.

Dilutioncore

Your ownership share shrinking because the company issued new shares. A pre-revenue company's real product is shares; check share count over three to five years before you check anything else.

Distributioncore

Large holders selling into retail demand. The classic signature is rising discussion volume with a flat or falling price and increasingly defensive tone.

Divergencecore

When sentiment and price disagree. Rising mentions with a falling price is a warning; a rising price with flat mentions can mean quiet accumulation. The divergence carries more information than either signal alone.

Drawdowncore

The fall from an asset's peak to its trough, in percent. Tier 2 assets routinely draw down 30–50% inside an intact uptrend, which is why drawdown alone is a poor exit signal.

Drill results / interceptASX

The assay results from an exploration drill hole. An "intercept" is the mineralised section — reported as grade over width at a depth. Headline numbers are routinely the single best intercept out of many; read the full table.

Due diligencecore

Independent verification before committing money. Reading a forum is not due diligence. Reading filings, announcements and the bear case is.

DUV lithographyUS

Deep ultraviolet lithography — the chipmaking technique below EUV, with "immersion" DUV using a liquid layer to print finer features. It matters to speculation because a single supplier has dominated it, and the July 2026 report of Chinese domestic immersion DUV entering production was enough to move the whole semiconductor equipment complex. Producing a handful of tools is not the same as high-volume manufacturing, where yield, overlay and reliability decide.

EDGARUS

The SEC's public filing database for US-listed companies. The American equivalent of the ASX announcements platform, and the primary source for anything about a US small cap.

Emergentcore

Stage 2 of the narrative lifecycle. Specialist forums and a few analysts have named the theme and ticker lists are circulating, but it hasn't reached mainstream media. This is where research effort pays most.

Employee secondary salealt

Current or former staff selling their vested shares in a private company before it lists, usually to institutional buyers on a secondary marketplace. Large volumes of it — such as the billions reportedly sold by OpenAI employees ahead of a possible IPO — are a useful gauge of insider conviction about near-term listing timing and price, though it says nothing about whether outside retail investors will get access on similar terms.

EscrowASX

Shares locked up and unable to be sold for a set period after a listing. When escrow ends, a large block of stock becomes sellable on a known date — a dated, mechanical catalyst.

Euphoriccore

The top sentiment reading: "can't lose" talk, leverage discussion, mainstream coverage. It usually indicates saturation, because the marginal buyer at that point knows the least.

Falsifiablecore

Capable of being proven wrong by an observation. "The company will succeed" is not falsifiable. "The August cashflow report will show more than four quarters of runway" is. Only falsifiable thesis points are useful.

Federal preemptionalt

A legal doctrine under which federal law overrides a conflicting state law. A federal judge invoked it in July 2026 to block Minnesota's prediction-market ban, finding it likely conflicted with the CFTC's exclusive jurisdiction over swaps under the Commodity Exchange Act — a finding that, if it holds, would blunt other states' ability to ban the category outright.

Floatcore

The shares actually available to trade, excluding locked-up, escrowed or closely held stock. A small float means large price moves on modest volume, in both directions.

FOMObehaviour

Fear of missing out. Reliably worst at the exact moment when the least upside remains, because that's when the visible evidence of other people's gains peaks.

Frontier marketsalt

Markets less developed than emerging markets — smaller, less liquid, harder to access. Currency, custody and governance risk stack on top of ordinary market risk.

GradeASX

How much of the target mineral is in the rock — grams per tonne for gold, percent for most others. High grade over a narrow width can be economically worthless; grade alone tells you very little.

Gross-margin compressioncore

Revenue growing while the percentage kept after direct costs shrinks. The reason it matters more than the revenue line for a growth story is that it separates three very different situations: a one-off cost, a shift in product mix toward lower-margin goods, or a permanent loss of pricing power. Only the third is a broken thesis, and companies describe all three in the same language.

Graded card / population reportalt

A collectible card authenticated and condition-graded by a service such as PSA. The population report shows how many exist at each grade. A one-grade difference can mean a tenfold price difference, which makes grading both a gate and a lottery.

HIN / SRNASX

Holder Identification Number (broker-sponsored, CHESS) and Securityholder Reference Number (issuer-sponsored, held with the company's registry). Either means the shares are registered in your name; a custodial account gives you neither.

Hit ratecore

The proportion of your positions that make money. A speculative book can run a low hit rate and still work, provided losses are small and winners are held. Judging yourself on hit rate alone pushes you toward taking small gains early.

HotCopperASX

Australia's largest retail stock forum. Genuinely useful as a sentiment instrument; treated on this page as Tier C — never evidence of a fact, only evidence of what people are saying.

Hype cyclecore

The five-stage arc a narrative travels: Latent → Emergent → Acceleration → Saturation → Decay. Knowing which stage you're in matters more than knowing whether the underlying story is true.

Illiquiditycore

Not being able to buy or sell without moving the price against yourself. The defining risk of Tier 3 assets and the reason a screen price there is an opinion rather than a quote.

Inferred / Indicated / MeasuredASX

The three JORC confidence levels for a mineral resource, from lowest to highest. Movement up this ladder is a genuine, dated de-risking event and one of the better catalysts available in exploration.

IPOcore

Initial public offering — a company's first listing on an exchange. Speculatively interesting mostly because of what follows: escrow expiries, lock-up expiries and the first reported result.

JORC CodeASX

The Australasian reporting standard governing how mineral resources and reserves may be publicly described. It's why ASX resource announcements are comparable at all, and why a "resource" means something specific rather than whatever the company would like.

Journal (decision journal)behaviour

A written record made before entry — thesis, catalyst, falsifiable points, bear case, exit plans, time stop — appended and never rewritten. It exists because your memory of your own conviction is unreliable in exactly the way that costs money.

Latentcore

Stage 1 of the narrative lifecycle. A real change has happened — policy, technology, supply shock — but almost nobody has connected it to specific assets yet. Best risk/reward, hardest to tell apart from noise.

Liquiditycore

How easily an asset converts to cash at a fair price. Measured by traded value and spread, not by market cap. It's a scored dimension on this page because illiquidity turns a paper loss into a real trapped one.

Lock-up expiryUS

The date insiders and early investors become free to sell after an IPO. A dated, mechanical supply event with a predictable direction and an unpredictable size.

MAC — Medicare Administrative ContractorUS

A private company contracted by CMS to process Medicare claims and make regional coverage determinations for specific devices or procedures. A MAC coverage dispute or reversal can move a small medtech's revenue directly — see AVITA Medical's "MAC overhang" and Orthofix's bone-growth-stimulator reimbursement case on the watchlist, both examples of the same reimbursement-as-catalyst mechanism.

Market capcore

Share price × shares on issue. Widely quoted and frequently misleading for speculation, because it says nothing about whether you could actually exit. Use ADTV for that.

Market surveillancealt

The internal monitoring systems an exchange runs to detect suspicious trading patterns. A CFTC-registered designated contract market is required to maintain one and refer suspected violations — Kalshi's surveillance team flagging a White House staffer's trades in July 2026 is the system working as licensed, not evidence of a voluntary compliance edge over a competitor operating under the same obligation.

Meme stock / memecoincore

An asset whose value derives entirely from attention rather than cash flows or assets. Tier 4 on this page, with a base case of total loss — not a tail risk, the base case.

Microcap / nano-capcore

The smallest listed companies. Thin order books, wide spreads, minimal analyst coverage and heavy dilution risk. Where genuine research edge is most available and where illiquidity is most dangerous.

Minimum bid price deficiencyUS

Nasdaq's rule requiring a listed stock to trade at or above $1.00 for 30 consecutive business days; falling short triggers a compliance notice and, eventually, delisting risk. A company that has already used its standard compliance period (often via prior reverse splits) faces a harder deadline the next time it happens — which is what makes a shareholder vote on a further split a genuinely dated, binding event rather than routine housekeeping.

MOFCOMcore

China's Ministry of Commerce, which administers export controls on rare earths and other strategic minerals. Its announcements are Tier A primary sources and are the actual driver of the critical-minerals narrative — the commodity price is downstream of what MOFCOM publishes.

Narrativecore

A compressed story that lets people buy without doing work. It is the actual product being traded in speculation. Tracking its lifecycle stage matters more than tracking the price.

Neuromorphic computingASX

Chip designs that mimic the structure of biological neurons, aiming for very low-power AI processing. On this page it appears as a case study in a real technology with a chronically late revenue story.

Notional volumealt

The total face value of contracts traded, as distinct from money at risk. Used for prediction-market comparisons; it makes volumes look larger than the capital actually committed.

Offtake agreementASX

A contract where a buyer commits in advance to purchase future production. It converts a geology story into a commercial one and is one of the strongest genuine de-risking events for an explorer.

Options premiumUS

The price paid for an options contract. Aggregate retail options premium is used here as a positioning indicator — record premium concentrated in one sector tells you about crowding, not about value.

Order bookcore

The live list of buy and sell orders at each price. A "thin" book means few orders, so a modest trade moves the price a long way. Look at the book before trusting the last traded price.

Overhangcore

A known block of stock likely to hit the market — unexercised options, performance rights, escrowed shares. It caps upside because every rally meets willing sellers.

Physician Fee Schedule (PFS)US

The annual CMS rule setting what Medicare pays for each physician service in the United States. It runs on a fixed calendar — proposed rule in July, comment period, final rule in the autumn, rates effective 1 January — which makes it one of the few genuinely dated, mandatory catalysts available outside exchange filings.

Position sizingbehaviour

How much money goes into one position. The most powerful risk control available, and the one most often abandoned after a couple of wins. Decide the caps in writing before you have an opinion about any specific asset.

Pre-IPO / secondariesalt

Buying shares in a private company before it lists, usually from an existing holder. Access is the whole game, and retail-accessible routes typically carry fee layers that consume the edge.

Prediction marketalt

An exchange where contracts pay out based on whether a real-world event occurs. Because positions resolve objectively and quickly, they're excellent calibration training and a poor compounding vehicle.

Pre-mortembehaviour

Before entering, write the story of how the position lost 90% — as a narrative in past tense, not a list of risks. The failure paths you can imagine in advance are the ones you'll recognise early enough to act on.

Pre-revenuecore

A company with no sales. Its value rests entirely on a story about the future, which is the formal definition of a Tier 2 or Tier 3 speculation.

Primary sourcecore

Filings, exchange announcements, regulator publications, exchange data. Tier A on this page — the only category that can support a factual claim on its own.

Pump and dumpbehaviour

Promoting an asset to inflate its price, then selling into the demand you created. Illegal in regulated markets and endemic in unregulated ones. The tell is promotion with strong price targets and no falsifiable claims.

QCEXalt

A CFTC-registered derivatives exchange acquired by Polymarket as its route back into the regulated US market after years operating offshore. Owning the licence is a necessary condition for US access; it says nothing on its own about whether the surveillance and compliance systems behind it match the exchange Polymarket is trying to catch.

Quantum pure-playUS

A company whose entire business is quantum computing, as opposed to a large firm with a quantum division. Pure-plays offer maximum exposure to the narrative and minimum protection from revenue, which is precisely why they move so violently.

Quarters of funding availableASX

Item 8.3 of the ASX Appendix 5B: the company's own stated estimate of how many quarters it can continue operating at its current burn. Worth knowing that this is disclosed rather than derived — the runway arithmetic is done for you and lodged, which is a useful shortcut and a reason to be sceptical of anyone claiming it as proprietary work.

Rampingbehaviour

Coordinated online promotion of a stock, often dressed as research. Anonymous accounts, confident price targets, no falsifiable claims, and hostility toward anyone who disagrees.

Rare earthsASX

Seventeen metallic elements essential to magnets, EVs, defence hardware and electronics. Not geologically rare; hard and dirty to separate, and historically concentrated in Chinese processing — which is what makes them a policy narrative rather than just a commodity.

Reflexivitycore

When price movement itself changes the fundamentals — a rising price lets a company raise cheap capital, which improves its prospects, which lifts the price. It works identically in reverse, which is what makes speculative collapses so fast.

Reimbursement riskUS

The risk that a healthcare company's revenue changes because a payer changes what it pays, not because anything about the product changed. For a company concentrated in one billing code it is the dominant risk and the dominant catalyst simultaneously — the same fact seen from two sides.

Relative value units (RVUs)US

The weighting CMS assigns to each medical procedure, reflecting work, practice expense and liability. Payment is roughly RVUs × the conversion factor, so a change to one code's RVUs is where a fee-schedule rule actually bites — and it is the part of the rule that headlines skip in favour of the single conversion-factor number.

Reseller channelcore

Selling through a distributor or reseller rather than directly to the end customer. It buys reach into markets a small company cannot cover itself, and it costs margin, because the intermediary takes a cut. When a contract announcement names a reseller rather than the end buyer, that is a disclosed clue about the profitability of the revenue — and it is in the announcement, not the headline.

Resource upgradeASX

Reclassifying a mineral resource to a higher confidence category under JORC. A real, dated de-risking event rather than a promotional announcement.

Reverse stock splitcore

Consolidating multiple existing shares into one to lift the nominal share price, most often used to cure a minimum-bid-price deficiency and avoid delisting. It changes nothing about the underlying business, cash position or proportional ownership — only the number on the screen — and a company doing it for the second or third time in a few years is disclosing, mechanically, that the underlying dilution problem was never solved the first time.

Round-trip costalt

Everything it costs to buy and later sell — commissions, auction fees, buyer's premium, grading, shipping, insurance. In collectibles this runs 10–20%, meaning the asset must appreciate substantially before you break even.

Runwaycore

How long a company can operate before it runs out of cash, usually expressed in quarters. Short runway means a discounted capital raise is coming, whatever else the company is announcing.

Saturationcore

Stage 4 of the narrative lifecycle. General news coverage, an ETF launches, and the marginal buyer knows nothing about the theme. The definitive tell: genuinely good news stops moving prices.

Scheme of arrangementASX

The court-approved mechanism by which most Australian takeovers complete, requiring a target-shareholder vote and judicial sign-off. Speculatively it marks the end rather than the start: once a competing bidder withdraws and a scheme is on foot, the interesting uncertainty has resolved and what remains is process.

Self-certification (event contracts)alt

The process by which a CFTC-registered exchange lists a new contract by certifying to the regulator that it complies with the rules, rather than waiting for prior approval. It is the mechanism behind the explosion in prediction-market products — tens of thousands of contracts on a single event series. A regulator restricting blanket, template-based self-certification does not ban anything; it slows the rate at which new things to bet on can appear, which is a growth-rate constraint disguised as a procedural notice.

Sell-the-newscore

A widely anticipated catalyst produces a flat or negative reaction because it was already priced in, and the anticipating buyers become sellers on resolution. The most common way a correct thesis still loses money.

Sentimentcore

The prevailing emotional tone of the crowd, scored here Fearful → Cautious → Neutral → Excited → Euphoric. Directional and qualitative, never a measurement.

Shell companycore

A listed entity with no meaningful operations, kept alive for its listing. One that has been a mining explorer, then a cannabis play, then an AI play is selling narratives rather than building anything.

Short interestUS

The proportion of a company's shares sold short. High short interest in a small float can produce violent upward moves as shorts are forced to buy back — a mechanical event, not a validation of the story.

SMR — small modular reactorcore

A compact, factory-built nuclear reactor design. Central to the nuclear-revival narrative because it promises faster, cheaper deployment than conventional plants — a promise still largely unproven at commercial scale.

Sovereign capabilityASX

A government's stated requirement that certain equipment be designed, built and sustained domestically rather than imported. It is a powerful narrative generator for local suppliers because it converts a policy preference into a procurement rule. The speculative caution is that it names a type of company, not an amount of money — announced programs are often small relative to the revenue expectations built on top of them.

Speculationcore

Buying an asset because you expect other people's beliefs about it to change, rather than because you expect the asset to pay you. If it pays you nothing when the story fails to spread, you are speculating.

SpodumeneASX

The main hard-rock lithium ore mined in Australia. Its spot price is the practical reference point for whether the "lithium recovery" narrative is actually turning.

18 · Full documentation

The complete system, in four documents. Updated by the daily scan.

plan.md →

The beginner's plan: definitions, risk psychology, categories, how to start, research routine, narrative tracking, decision journaling, traps.

skills.md →

System architecture: the nine sub-agents, daily workflow, source tiering, output formats, integrity checklist, and an honest list of limitations.

spec.md →

Deep dive: ASX and US microcaps, crypto narratives, AI hype cycles, collectibles, prediction markets, catalysts, risk tiers, sentiment analysis, scoring.

ai_infrastructure.md →

AI Infrastructure Agent in full: the capex numbers, the power-bottleneck shift, Goldman's hedge-fund positioning data, layer-by-layer segmentation, ASX exposure, risk tiering and early-stage watchlist.

ai_software.md →

AI Software Agent in full: the under-owned positioning fact, monetisation evidence, the pay-for-work-done pricing shift, the ROI reckoning counter-case, Palantir vs Snowflake, risk tiering and watchlist.

frontier_tech.md →

Frontier Tech Agent in full: robotaxi commercialisation, solid-state timelines, the humanoid scaling-vs-formation correction, AI biotech's countable metric, energy crossover, ASX input exposure.

tracking_system.md →

The tracking system specification: seven categories, seven field definitions with scoring anchors, five update cadences, the markdown register and the JSON schema rules.

tables.html →

All nine sentiment tables as a clean semantic HTML fragment — no inline styles, no scripts, no dependencies. Copy any table straight into a page and it inherits that page's styling.

schema.json →

Machine-readable register — 12 entries with scores, catalysts, attributed narrative claims, source tiers and validation rules. What the daily run reads and writes.

history.md →

Append-only log of every opportunity this system has ever flagged — plus each day's Idea of the Day and its reasoning, kept permanently so the calls can be judged after the fact.

How this page is produced

A nine-agent pipeline runs once each day at 6:30 AWST: a planning pass sets the day's source budget; a research pass scans announcements, filings, forums and media; narrative, sentiment and risk-tiering passes classify what it finds; a scoring pass ranks it; a repo pass rewrites this page and appends to the history log; and a self-evaluation pass checks the run against the brief before it commits. Full detail in skills.md.

Known limitations, stated plainly: no live market data is used — no prices, no market caps, no volumes. Sentiment is read qualitatively, not computed. The scan is recency-biased, so genuinely latent narratives (the most valuable stage) are the ones it is least likely to catch. Scores have never been backtested against forward returns. Everything is point-in-time and can be wrong within hours.

Sources used in today's scan

6 August 2026 — Run #10. Around twenty queries. Forum and social sources are treated as evidence of sentiment only, never of fact. No sponsored or promotional coverage was used as a source in this run. A new benchmark discrepancy was flagged rather than resolved this run: two sources give conflicting China lithium carbonate benchmarks (CNY 140,000/t vs ¥146,000/t) — logged in §3, not reconciled.

Primary and regulatory (Tier A): CMS — CY2027 Physician Fee Schedule proposed rule fact sheet (carried forward) · IonQ IR — Q2 2026 results release · ENvue Medical — DEF 14A proxy statement, via StockTitan (carried forward)

Reputable secondary (Tier B): Benzinga — IonQ Q2 double beat, raised outlook, muted after-hours move · StockAnalysis.com — SpaceX 5 Aug close $125.33 · Forbes — nearly 1bn SpaceX shares unlock 6 Aug (carried forward) · TradingKey — SpaceX revenue +92%, capex doubles, stock drops (carried forward) · MarketBeat — quantum earnings cluster, what to watch · Kalkine — Solstice fresh RC assays, 3 Aug (carried forward) · Rare Earth Exchanges — China index at 267.0, rechecked · MacroMicro — Nd/Pr metal prices, rechecked · CFTC — Enforcement Division prediction-markets advisory (carried forward) · Capital.com — DroneShield, no new information (carried forward) · Discovery Alert — offtake negotiations still early-stage (carried forward) · Mining.com.au — Krakatoa second field season, no assays yet (carried forward) · Investing.com — lithium carbonate benchmark, flagged discrepancy · Tech Wire Asia — Chinese DUV production scale (carried forward)

Sentiment only (Tier C — never used as evidence of a fact): AltIndex — r/wallstreetbets mention tracker (carried forward)

Coverage gap logged — tenth consecutive run. No HotCopper highlights piece with thematic overlap to the current watchlist was retrievable today, and no r/ASX_Bets summary was retrievable. ASX retail sentiment readings are effectively still carried forward from mid-to-late July and are now well over six weeks stale. This remains the single largest known weakness in the current page: the ASX half of the watchlist is being sentiment-scored from stale forum data, and the sentiment dimension carries 15 of the 100 available points. Any ASX sentiment cell should be read as "last observed," not "current."

1 · Start here — what speculation actually is

How a beginner should actually start

2 · Idea of the day

Why this, and why today

The case against reading this as clean good news

What would prove this wrong

Risk-tier reality check

How you'd actually research this yourself

What did not get picked today, and why

3 · Daily watchlist

Retired from the watchlist today

4 · Narrative tracker

5 · Sentiment heatmap

Reading the heatmap honestly

The divergence patterns that matter

6 · Risk tiers

Tier 1 High risk, grounded narrative

Tier 2 Very high risk, hype-driven

Tier 3 Extreme risk, low liquidity

Tier 4 Meme-level speculation

7 · Scoring framework

75–100

55–74

35–54

0–34

The ten-minute triage

8 · Research routine & who to follow

Daily · 15 min

Weekly · 60–90 min

Monthly · 2–3 hrs

Quarterly

Source tiering — not all sources are equal

Where this system looks

ASX small & microcaps

US small & microcaps

Alternative assets

Cross-cutting

8.2 · Who's actually worth following

Tier A — primary. Start every serious question here.

Tier B — reputable secondary. Good for finding what to research.

Tier C — sentiment only. Never evidence of a fact.

The decision journal

9 · Getting access — choosing a broker

The questions that actually decide it

Where to compare, independently

10 · The six-week learning pathway

11 · Sandbox — simulated scenarios

12 · Traps

Structural

Social

Cognitive

Behavioural

13 · Thematic research buckets

The scale investors are working with

The core finding — the bottleneck moved

What hedge funds actually did

A new, single company now sits inside this bucket's own narrative

Must-watch early plays, as investors describe them

Risks

The contrarian fact that frames the bucket

The monetisation evidence

The mechanism that matters — pricing

The counter-narrative — the ROI reckoning

The two named comparisons

Risks

Autonomy — the category that actually crossed over

Solid-state batteries — real progress, wrong end market for the popular story

Humanoid robotics — the widest narrative-to-revenue gap

AI biotech — a genuinely new, countable metric

ASX exposure — genuine here, unlike AI software

Risks

14 · Cross-bucket risk tiering

Low risk (relative)

Medium risk

High risk

15 · Speculation-tracking system

Categories

Tracking fields

Update workflow

The register